<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/pharmaceuticals');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 5.863 </a> </div> </div> </div> <div > Journals </div> <div > Pharmaceuticals </div> </div> </header> <div > <div > <div > <div > <div > <ul > <li> <a > <div > Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge—Cell Binding Correlation </div> </a> </li> </ul> </div> </div> <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Pharmaceuticals </h1> <div > Pharmaceuticals is a <a >peer-reviewed</a>, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. The <a >Academy of Pharmaceutical Sciences (APS)</a> is partners of Pharmaceuticals and their members receive a discount on the article processing charge. <ul> <li>Open Access— free for readers, with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >PMC</a>, <a >Embase</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>. </li> <li>Journal Rank: JCR - Q1 (Pharmacology Pharmacy) / CiteScore - Q2 (Pharmaceutical Science)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.7 days after submission; acceptance to publication is undertaken in 3.4 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li>Testimonials: See what our authors say about Pharmaceuticals</li> <li>International Electronic Conference on Medicinal Chemistry (<a >https://sciforum.net/series/ecmc/latest</a>)</li> <li>Companion journals for Pharmaceuticals include: <a >Pharmacoepidemiology</a> and <a >Psychoactives</a>.</li> </ul> </div> <div > Impact Factor: 5.863 (2020) ; 5-Year Impact Factor: 5.85 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 1424-8247 </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: <a > Supplementary File 1 (ZIP, 1102 KiB) </a> </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> <a >Full-Text HTML</a> </div> </div> <div >Open AccessArticle</div> Graphene Oxide-Gold Nanorods Nanocomposite-Porphyrin Conjugate as Promising Tool for Cancer Phototherapy Performance <div > by <span ><div >Thabang Calvin Lebepe</div>, </span><span ><div >Sundararajan Parani</div>, </span><span ><div >Vuyelwa Ncapayi</div>, </span><span ><div >Rodney Maluleke</div>, </span><span ><div >Grace It Mwad Mbaz</div>, </span><span ><div >Olufunto Tolulope Fanoro</div>, </span><span ><div >Jose Rajendran Varghese</div>, </span><span ><div >Atsuki Komiya</div>, </span><span ><div >Tetsuya Kodama</div> and </span><span ><div >Oluwatobi Samuel Oluwafemi</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1295; https://doi.org/10.3390/ph14121295 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > The cancer mortality rate has increased, and conventional cancer treatments are known for having many side effects. Therefore, it is imperative to find a new therapeutic agent or modify the existing therapeutic agents for better performance and efficiency. Herein, a synergetic phototherapeutic agent [...] Read more. </div> <div > The cancer mortality rate has increased, and conventional cancer treatments are known for having many side effects. Therefore, it is imperative to find a new therapeutic agent or modify the existing therapeutic agents for better performance and efficiency. Herein, a synergetic phototherapeutic agent based on a combination of photothermal and photodynamic therapy is proposed. The phototherapeutic agent consists of water-soluble cationic porphyrin (5,10,15,20-tetrakis(<i>N</i>-methylpyridinium-3-yl)porphyrin, TMePyP), and gold nanorods (AuNRs) anchored on graphene-oxide (GO) sheet. The TMePyP was initially synthesized by Adler method, followed by methylation, while GO and AuNRs were synthesized using Hummer’s and seed-mediated methods, respectively. The structural and optical properties of TMePyP were confirmed using UV-Vis, zeta analyzer, PL, FTIR and NMR. The formation of both GO and AuNRs was confirmed by UV-Vis-NIR, FTIR, TEM and zeta analyzer. TMePyP and AuNRs were anchored on GO to form [email protected] nanocomposite. The as-synthesized nanocomposite was stable in RPMI and PBS medium, and, on irradiation, produced high heat than the bare AuNRs, with high photothermal efficiency. In addition, the nanocomposite produced higher singlet oxygen than TMePyP with high biocompatibility in the absence of light. These results indicated that the as-synthesized nanocomposite is a promising dual photodynamic and photothermal agent for cancer therapy. Full article </div> </div> <div > (This article belongs to the Special Issue Synthesis of Metal Nanoparticles and Their Pharmaceutical Applications) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Evaluation of Amebicidal and Cysticidal Activities of Antifungal Drug Isavuconazonium Sulfate against <i>Acanthamoeba</i> T4 Strains</a> <div > by <span ><div >Brian Shing</div>, </span><span ><div >Mina Balen</div> and </span><span ><div >Anjan Debnath</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1294; https://doi.org/10.3390/ph14121294 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > <i>Acanthamoeba</i> species of amebae are often associated with <i>Acanthamoeba</i> keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized into the active isavuconazole moiety. Isavuconazole was previously identified to have [...] Read more. </div> <div > <i>Acanthamoeba</i> species of amebae are often associated with <i>Acanthamoeba</i> keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized into the active isavuconazole moiety. Isavuconazole was previously identified to have amebicidal and cysticidal activity against <i>Acanthamoeba</i> T4 strains, but the activity of its prodrug, isavuconazonium sulfate, against trophozoites and cysts remains unknown. Since it is not known if isavuconazonium can be metabolized into isavuconazole in the human eye, we evaluated the activities of isavuconazonium sulfate against trophozoites and cysts of three T4 genotype strains of <i>Acanthamoeba.</i> Isavuconazonium displayed amebicidal activity at nanomolar concentrations as low as 1.4 nM and prevented excystation of cysts at concentrations as low as 136 μM. We also investigated the cysticidal activity of isavuconazonium sulfate in combination with a currently used amebicidal drug polyhexamethylene biguanide (PHMB). Although combination of isavuconazonium with PHMB did not elicit an obvious synergistic cysticidal activity, the combination did not cause an antagonistic effect on the cysts of <i>Acanthamoeba</i> T4 strains. Collectively, these findings suggest isavuconazonium retains potency against <i>Acanthamoeba</i> T4 strains and could be adapted for <i>Acanthamoeba</i> keratitis treatment. Full article </div> </div> <div > (This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Lichen-Derived Compounds and Extracts as Biologically Active Substances with Anticancer and Neuroprotective Properties <div > by <span ><div >Elżbieta Studzińska-Sroka</div>, </span><span ><div >Aleksandra Majchrzak-Celińska</div>, </span><span ><div >Przemysław Zalewski</div>, </span><span ><div >Dominik Szwajgier</div>, </span><span ><div >Ewa Baranowska-Wójcik</div>, </span><span ><div >Barbara Kaproń</div>, </span><span ><div >Tomasz Plech</div>, </span><span ><div >Marcin Żarowski</div> and </span><span ><div >Judyta Cielecka-Piontek</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1293; https://doi.org/10.3390/ph14121293 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Lichens are a source of chemical compounds with valuable biological properties, structurally predisposed to penetration into the central nervous system (CNS). Hence, our research aimed to examine the biological potential of lipophilic extracts of <i>Parmelia sulcata</i>, <i>Evernia prunastri</i>, <i>Cladonia uncialis</i>, [...] Read more. </div> <div > Lichens are a source of chemical compounds with valuable biological properties, structurally predisposed to penetration into the central nervous system (CNS). Hence, our research aimed to examine the biological potential of lipophilic extracts of <i>Parmelia sulcata</i>, <i>Evernia prunastri</i>, <i>Cladonia uncialis</i>, and their major secondary metabolites, in the context of searching for new therapies for CNS diseases, mainly glioblastoma multiforme (GBM). The extracts selected for the study were standardized for their content of salazinic acid, evernic acid, and (−)-usnic acid, respectively. The extracts and lichen metabolites were evaluated in terms of their anti-tumor activity, i.e. cytotoxicity against A-172 and T98G cell lines and anti-IDO1, IDO2, TDO activity, their anti-inflammatory properties exerted by anti-COX-2 and anti-hyaluronidase activity, antioxidant activity, and anti-acetylcholinesterase and anti-butyrylcholinesterase activity. The results of this study indicate that lichen-derived compounds and extracts exert significant cytotoxicity against GBM cells, inhibit the kynurenine pathway enzymes, and have anti-inflammatory properties and weak antioxidant and anti-cholinesterase properties. Moreover, evernic acid and (−)-usnic acid were shown to be able to cross the blood-brain barrier. These results demonstrate that lichen-derived extracts and compounds, especially (−)-usnic acid, can be regarded as prototypes of pharmacologically active compounds within the CNS, especially suitable for the treatment of GBM. Full article </div> </div> <div > (This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 12627 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein <div > by <span ><div >Anunay J. Pulukuri</div>, </span><span ><div >Anthony J. Burt</div>, </span><span ><div >Larissa K. Opp</div>, </span><span ><div >Colin M. McDowell</div>, </span><span ><div >Maryam Davaritouchaee</div>, </span><span ><div >Amy E. Nielsen</div> and </span><span ><div >Rock J. Mancini</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1292; https://doi.org/10.3390/ph14121292 - 10 Dec 2021 </div> <div > Abstract <div > Multidrug-Resistant (MDR) cancers attenuate chemotherapeutic efficacy through drug efflux, a process that transports drugs from within a cell to the extracellular space via ABC (ATP-Binding Cassette) transporters, including P-glycoprotein 1 (P-gp or ABCB1/MDR1). Conversely, Toll-Like Receptor (TLR) agonist immunotherapies modulate activity of tumor-infiltrating [...] Read more. </div> <div > Multidrug-Resistant (MDR) cancers attenuate chemotherapeutic efficacy through drug efflux, a process that transports drugs from within a cell to the extracellular space via ABC (ATP-Binding Cassette) transporters, including P-glycoprotein 1 (P-gp or ABCB1/MDR1). Conversely, Toll-Like Receptor (TLR) agonist immunotherapies modulate activity of tumor-infiltrating immune cells in local proximity to cancer cells and could, therefore, benefit from the enhanced drug efflux in MDR cancers. However, the effect of acquired drug resistance on TLR agonist efflux is largely unknown. We begin to address this by investigating P-gp mediated efflux of TLR 7/8 agonists. First, we used functionalized liposomes to determine that imidazoquinoline TLR agonists Imiquimod, Resiquimod, and Gardiquimod are substrates for P-gp. Interestingly, the least potent imidazoquinoline (Imiquimod) was the best P-gp substrate. Next, we compared imidazoquinoline efflux in MDR cancer cell lines with enhanced P-gp expression relative to parent cancer cell lines. Using P-gp competitive substrates and inhibitors, we observed that imidazoquinoline efflux occurs through P-gp and, for Imiquimod, is enhanced as a consequence of acquired drug resistance. This suggests that enhancing efflux susceptibility could be an important consideration in the rational design of next generation immunotherapies that modulate activity of tumor-infiltrating immune cells. Full article </div> </div> <div > (This article belongs to the Special Issue Anticancer Drugs 2021) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 19073 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II—Design, Synthesis, and Evaluation <div > by <span ><div >Michal Maryška</div>, </span><span ><div >Lucie Svobodová</div>, </span><span ><div >Wim Dehaen</div>, </span><span ><div >Martina Hrabinová</div>, </span><span ><div >Michaela Rumlová</div>, </span><span ><div >Ondřej Soukup</div> and </span><span ><div >Martin Kuchař</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1291; https://doi.org/10.3390/ph14121291 - 10 Dec 2021 </div> <div > Abstract <div > Kynurenic acid is a neuroprotective metabolite of tryptophan formed by kynurenine aminotransferase (KAT) catalyzed transformation of kynurenine. However, its high brain levels are associated with cognitive deficit and with the pathophysiology of schizophrenia. Although several classes of KAT inhibitors have been published, the [...] Read more. </div> <div > Kynurenic acid is a neuroprotective metabolite of tryptophan formed by kynurenine aminotransferase (KAT) catalyzed transformation of kynurenine. However, its high brain levels are associated with cognitive deficit and with the pathophysiology of schizophrenia. Although several classes of KAT inhibitors have been published, the search for new inhibitor chemotypes is crucial for the process of finding suitable clinical candidates. Therefore, we used pharmacophore modeling and molecular docking, which predicted derivatives of heterocyclic amino ketones as new potential irreversible inhibitors of kynurenine aminotransferase II. Thiazole and triazole-based amino ketones were synthesized within a SAR study and their inhibitory activities were evaluated in vitro. The observed activities confirmed our computational model and, moreover, the best compounds showed sub-micromolar inhibitory activity with 2-alaninoyl-5-(4-fluorophenyl)thiazole having IC<sub>50</sub> = 0.097 µM. Full article </div> </div> <div > (This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 19030 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Discovery of a Novel Template, 7-Substituted 7-Deaza-4′-Thioadenosine Derivatives as Multi-Kinase Inhibitors <div > by <span ><div >Karishma K. Mashelkar</div>, </span><span ><div >Woong Sub Byun</div>, </span><span ><div >Hyejin Ko</div>, </span><span ><div >Kisu Sung</div>, </span><span ><div >Sushil K. Tripathi</div>, </span><span ><div >Seungchan An</div>, </span><span ><div >Yun A Yum</div>, </span><span ><div >Jee Youn Kwon</div>, </span><span ><div >Minjae Kim</div>, </span><span ><div >Gibae Kim</div>, </span><span ><div >Eun-Ji Kwon</div>, </span><span ><div >Hyuk Woo Lee</div>, </span><span ><div >Minsoo Noh</div>, </span><span ><div >Sang Kook Lee</div> and </span><span ><div >Lak Shin Jeong</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1290; https://doi.org/10.3390/ph14121290 - 10 Dec 2021 </div> <div > Abstract <div > The development of anticancer drugs remains challenging owing to the potential for drug resistance. The simultaneous inhibition of multiple targets involved in cancer could overcome resistance, and these agents would exhibit higher potency than single-target inhibitors. Protein kinases represent a promising target for [...] Read more. </div> <div > The development of anticancer drugs remains challenging owing to the potential for drug resistance. The simultaneous inhibition of multiple targets involved in cancer could overcome resistance, and these agents would exhibit higher potency than single-target inhibitors. Protein kinases represent a promising target for the development of anticancer agents. As most multi-kinase inhibitors are heterocycles occupying only the hinge and hydrophobic region in the ATP binding site, we aimed to design multi-kinase inhibitors that would occupy the ribose pocket, along with the hinge and hydrophobic region, based on ATP-kinase interactions. Herein, we report the discovery of a novel 4′-thionucleoside template as a multi-kinase inhibitor with potent anticancer activity. The in vitro evaluation revealed a lead <b>1g</b> (7-acetylene-7-deaza-4′-thioadenosine) with potent anticancer activity, and marked inhibition of TRKA, CK1δ, and DYRK1A/1B kinases in the kinome scan assay. We believe that these findings will pave the way for developing anticancer drugs. Full article </div> </div> <div > (This article belongs to the Special Issue Anticancer Drugs 2021) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 2056 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes <div > by <span ><div >Giuseppe Floresta</div>, </span><span ><div >Antonino Nicolò Fallica</div>, </span><span ><div >Vincenzo Patamia</div>, </span><span ><div >Valeria Sorrenti</div>, </span><span ><div >Khaled Greish</div>, </span><span ><div >Antonio Rescifina</div> and </span><span ><div >Valeria Pittalà</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1289; https://doi.org/10.3390/ph14121289 - 10 Dec 2021 </div> <div > Abstract <div > HO-1 overexpression has been reported in several cases/types of human malignancies. Unfortunately, poor clinical outcomes are reported in most of these cases, and the inhibition of HO-1 is considered a valuable and proven anticancer approach. To identify novel hit compounds suitable as HO-1 [...] Read more. </div> <div > HO-1 overexpression has been reported in several cases/types of human malignancies. Unfortunately, poor clinical outcomes are reported in most of these cases, and the inhibition of HO-1 is considered a valuable and proven anticancer approach. To identify novel hit compounds suitable as HO-1 inhibitors, we report here a fragment-based approach where ligand joining experiments were used. The two most important parts of the classical structure of the HO-1 inhibitors were used as a starting point, and 1000 novel compounds were generated and then virtually evaluated by structure and ligand-based approaches. The joining experiments led us to a novel series of indole-based compounds. A synthetic pathway for eight selected molecules was designed, and the compounds were synthesized. The biological activity revealed that some molecules reach the micromolar activity, whereas molecule <b>4d</b> inhibits the HO-1 with an IC<sub>50</sub> of 1.03 μM. This study suggested that our joining approach was successful, and a novel hit compound was generated. These results are ongoing for further development. Full article </div> </div> <div > (This article belongs to the Section Medicinal Chemistry) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessOpinion</div> A New Paradigm to Indicate Antidepressant Treatments <div > by <span ><div >Anton J. M. Loonen</div>, </span><span ><div >Taichi Ochi</div>, </span><span ><div >Lisanne M. Geers</div>, </span><span ><div >German G. Simutkin</div>, </span><span ><div >Nikolay A. Bokhan</div>, </span><span ><div >Daniël J. Touw</div>, </span><span ><div >Bob Wilffert</div>, </span><span ><div >Alexander N. Kornetov</div> and </span><span ><div >Svetlana A. Ivanova</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1288; https://doi.org/10.3390/ph14121288 - 10 Dec 2021 </div> <div > Abstract <div > This article develops the idea that clinical depression can be seen as a typical human response, largely rooted in human culture, to events of loss or times of adversity. Various biological, psychological, and social factors may cause some individuals to have a depressive [...] Read more. </div> <div > This article develops the idea that clinical depression can be seen as a typical human response, largely rooted in human culture, to events of loss or times of adversity. Various biological, psychological, and social factors may cause some individuals to have a depressive reaction that is ineffectually limited in time and/or severity. Recovery occurs mainly based on natural resilience mechanisms, which come into play spontaneously, but which are sometimes inhibited or blocked by specific pathological biopsychosocial mechanisms. One of the mechanisms for this could be the influence of the circuits that regulate pleasure and happiness, along the dorsal diencephalic connection (DDC) pathway from the forebrain to the midbrain via the habenula. Therapy works by undermining the biopsychosocial factors that prevent the natural recovery mechanism from working. Treatment should, therefore, be seen as facilitating rather than causing natural recovery. This approach is in line with the high recovery rate after placebo treatments and the positive influence of pharmacological treatments with completely different sites of action. Acceptance of this model means that when studying new treatments for depression, a new paradigm must be applied in which the relative value of antidepressant treatment is specifically weighted in terms of enabling the natural resilience process. Full article </div> </div> <div > (This article belongs to the Section Pharmacology) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> <a >Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal <i>SHP-1 </i>and<i> SOCS-3 </i>Hypermethylation: In Vitro and In Silico Evaluation</a> <div > by <span ><div >Futoon Abedrabbu Al-Rawashde</div>, </span><span ><div >Muhammad Farid Johan</div>, </span><span ><div >Wan Rohani Wan Taib</div>, </span><span ><div >Imilia Ismail</div>, </span><span ><div >Syed Ahmad Tajudin Tuan Johari</div>, </span><span ><div >Belal Almajali</div>, </span><span ><div >Abdullah Saleh Al-wajeeh</div>, </span><span ><div >Mansoureh Nazari V.</div> and </span><span ><div >Hamid Ali Nagi Al-Jamal</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1287; https://doi.org/10.3390/ph14121287 - 09 Dec 2021 </div> <div > Abstract <div > Epigenetic silencing of tumor suppressor genes (TSGs) plays an essential role in cancer pathogenesis, including acute myeloid leukemia (AML). All of<i> SHP-1</i>, <i>SOCS-1</i>, and<i> SOCS-3</i> are TSGs that negatively regulate JAK/STAT signaling. Enhanced re-expression of TSGs through de-methylation represents a therapeutic [...] Read more. </div> <div > Epigenetic silencing of tumor suppressor genes (TSGs) plays an essential role in cancer pathogenesis, including acute myeloid leukemia (AML). All of<i> SHP-1</i>, <i>SOCS-1</i>, and<i> SOCS-3</i> are TSGs that negatively regulate JAK/STAT signaling. Enhanced re-expression of TSGs through de-methylation represents a therapeutic target in several cancers. Thymoquinone (TQ) is a major component of <i>Nigella sativa</i> seeds with anticancer effects against several cancers. However, the effects of TQ on DNA methylation are not entirely understood. This study aimed to evaluate the ability of TQ to re-express <i>SHP-1</i>, <i>SOCS-1</i>, and<i> SOCS-3</i> in MV4-11 AML cells through de-methylation. Cytotoxicity, apoptosis, and cell cycle assays were performed using WSTs-8 kit, Annexin V-FITC/PI apoptosis detection kit, and fluorometric-red cell cycle assay kit, respectively. The methylation of <i>SHP-1</i>, <i>SOCS-1</i>, and <i>SOCS-3 </i>was evaluated by pyrosequencing analysis. The expression of<i> SHP-1</i>, <i>SOCS-1</i>, <i>SOCS-3</i>, <i>JAK2</i>, <i>STAT3</i>, <i>STAT5A</i>, <i>STAT5B</i>, <i>FLT3</i>-ITD, <i>DNMT1</i>, <i>DNMT3A</i>, <i>DNMT3B</i>,<i> TET2</i>, and<i> WT1</i> was assessed by RT-qPCR. The molecular docking of TQ to JAK2, STAT 3, and STAT5 was evaluated. The results revealed that TQ significantly inhibited the growth of MV4-11 cells and induced apoptosis in a dose- and time-dependent manner. Interestingly, the results showed that TQ binds the active pocket of JAK2, STAT3, and STAT5 to inhibit their enzymatic activity and significantly enhances the re-expression of <i>SHP-1</i> and <i>SOCS-3</i> through de-methylation. In conclusion, TQ curbs MV4-11 cells by inhibiting the enzymatic activity of JAK/STAT signaling through hypomethylation and re-expression of JAK/STAT negative regulators and could be a promising therapeutic candidate for AML patients. Full article </div> </div> <div > (This article belongs to the Section Pharmacology) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers <div > by <span ><div >Petar Saric</div>, </span><span ><div >Kathleen A. Young</div>, </span><span ><div >Martin Rodriguez-Porcel</div> and </span><span ><div >Panithaya Chareonthaitawee</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1286; https://doi.org/10.3390/ph14121286 - 09 Dec 2021 </div> <div > Abstract <div > Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts [...] Read more. </div> <div > Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts for a significant share of sarcoid-related mortality. The clinical presentation of CS can range from absence of symptoms to conduction abnormalities, heart failure, arrhythmias, valvular disease, and sudden cardiac death. Given the significant morbidity and mortality associated with CS, timely diagnosis is important. Traditional imaging modalities and histologic evaluation by endomyocardial biopsy often provide a low diagnostic yield. Cardiac positron emission tomography (PET) has emerged as a leading advanced imaging modality for the diagnosis and management of CS. This review article will summarize several aspects of the current use of PET in CS, including indications for use, patient preparation, image acquisition and interpretation, diagnostic and prognostic performance, and evaluation of treatment response. Additionally, this review will discuss novel PET radiotracers currently under study or of potential interest in CS. Full article </div> </div> <div > (This article belongs to the Special Issue Molecular Imaging for Cardiology: Radiopharmaceuticals for PET and SPECT) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational Approach <div > by <span ><div >Fatimawali</div>, </span><span ><div >Trina Ekawati Tallei</div>, </span><span ><div >Billy Johnson Kepel</div>, </span><span ><div >Mohammed Alorabi</div>, </span><span ><div >Ahmed M. El-Shehawi</div>, </span><span ><div >Widdhi Bodhi</div>, </span><span ><div >Sefren Geiner Tumilaar</div>, </span><span ><div >Ismail Celik</div>, </span><span ><div >Gomaa Mostafa-Hedeab</div>, </span><span ><div >Amany Abdel-Rahman Mohamed</div> and </span><span ><div >Talha Bin Emran</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1285; https://doi.org/10.3390/ph14121285 - 09 Dec 2021 </div> <div > Abstract <div > In many countries, the fruit of betel (<i>Piper betle</i> Linn) is traditionally used as medicine for treating malaria. It is a fatal disease, and existing medications are rapidly losing potency, necessitating the development of innovative pharmaceutics. The current study attempted to determine [...] Read more. </div> <div > In many countries, the fruit of betel (<i>Piper betle</i> Linn) is traditionally used as medicine for treating malaria. It is a fatal disease, and existing medications are rapidly losing potency, necessitating the development of innovative pharmaceutics. The current study attempted to determine the compounds in the n-hexane fraction of betel fruit extract and investigate the potential inhibition of bioactive compounds against aspartic protease plasmepsin 1 (PDB ID: 3QS1) and plasmepsin 2 (PDB ID: 1LEE) of <i>Plasmodium falciparum</i> using a computational approach. The ethanol extract was fractionated into n-hexane and further analyzed using gas chromatography-mass spectrometry (GC-MS) to obtain information regarding the compounds contained in betel fruit. Each compound’s potential antimalarial activity was evaluated using AutoDock Vina and compared to artemisinin, an antimalarial drug. Molecular dynamics simulations (MDSs) were performed to evaluate the stability of the interaction between the ligand and receptors. Results detected 20 probable compounds in the n-hexane extract of betel fruit based on GC-MS analysis. The docking study revealed that androstan-17-one,3-ethyl-3-hydroxy-, (5 alpha)- has the highest binding affinity for plasmepsin 1 and plasmepsin 2. The compound exhibits a similar interaction with artemisinin at the active site of the receptors. The compound does not violate Lipinski’s rules of five. It belongs to class 5 toxicity with an LD<sub>50</sub> of 3000 mg/kg. MDS results showed stable interactions between the compound and the receptors. Our study concluded that androstan-17-one,3-ethyl-3-hydroxy-, (5 alpha)- from betel fruit has the potential to be further investigated as a potential inhibitor of the aspartic protease plasmepsin 1 and plasmepsin 2 of <i>Plasmodium falciparum</i>. Full article </div> </div> <div > (This article belongs to the Section Medicinal Chemistry) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 423 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> New Method for the Monitoring of Antidepressants in Oral Fluid Using Dried Spot Sampling <div > by <span ><div >Sofia Soares</div>, </span><span ><div >Tiago Rosado</div>, </span><span ><div >Mário Barroso</div> and </span><span ><div >Eugenia Gallardo</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1284; https://doi.org/10.3390/ph14121284 - 08 Dec 2021 </div> <div > Abstract <div > The increase in the consumption of antidepressants is a public health problem worldwide, as these are a class of compounds widely used in the treatment of several illnesses, such as depression and anxiety. This work aimed to develop and optimize a method for [...] Read more. </div> <div > The increase in the consumption of antidepressants is a public health problem worldwide, as these are a class of compounds widely used in the treatment of several illnesses, such as depression and anxiety. This work aimed to develop and optimize a method for the quantification of a number of antidepressants and their metabolites (fluoxetine, venlafaxine, <i>O</i>-desmethylvenlafaxine, citalopram, sertraline, and paroxetine) in 100 µL of oral fluid using the dried saliva spots (DSS) sampling approach and gas chromatography coupled with tandem mass spectrometry (GC–MS/MS). The method was validated, presenting linearity within the studied range, with detection and quantification limits ranging between 10 and 100 ng/mL, and coefficients of determination (R<sup>2</sup>) of at least 0.99 for all analytes. Recoveries were between approximately 13 and 46%. The analysis of precision and accuracy presented acceptable coefficients of variation and relative errors, considering the criteria usually accepted in the validation of bioanalytical procedures. The method herein described is the first to be reported using DSS for the extraction of antidepressants, proving to be a sensitive, simple, and fast alternative to conventional techniques, and capable of being routinely applied in clinical and forensic toxicology scenarios. Full article </div> </div> <div > (This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 3115 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea <div > by <span ><div >Mi Jung Kwon</div>, </span><span ><div >Ho Suk Kang</div>, </span><span ><div >Joo-Hee Kim</div>, </span><span ><div >Ji Hee Kim</div>, </span><span ><div >Se Hoon Kim</div>, </span><span ><div >Nan Young Kim</div>, </span><span ><div >Eun Sook Nam</div>, </span><span ><div >Kyueng-Whan Min</div> and </span><span ><div >Hyo Geun Choi</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1283; https://doi.org/10.3390/ph14121283 - 08 Dec 2021 </div> <div > Abstract <div > Concerns about the hazards of statins on the development and mortality of stomach cancers remain controversial. Here, we investigated the likelihood of incident gastric cancers and related mortality depending on statin exposure, statin type, and the duration of use. This nested case–control-designed study [...] Read more. </div> <div > Concerns about the hazards of statins on the development and mortality of stomach cancers remain controversial. Here, we investigated the likelihood of incident gastric cancers and related mortality depending on statin exposure, statin type, and the duration of use. This nested case–control-designed study was composed of 8798 patients who were diagnosed with gastric cancer and matched with 35,192 controls at a 1:4 ratio based on propensity scores of age, sex, residential area, and income from the Korean National Health Insurance Service—Health Screening Cohort database (2002–2015). Propensity score overlap weighting was adjusted to balance the baseline covariates. Overlap propensity score-weighted logistic regression analyses were assessed to determine associations of the prior use of statins (any statin, hydrophilic statins vs. lipophilic statins) with incident gastric cancer and its mortality depending on the medication duration (&lt;180 days, 180–545 days, and &gt;545 days) after adjusting for multiple covariates. After adjustment, the use of any statin, hydrophilic statins, or lipophilic statins showed significant associations with lower odds for incident stomach cancer when used for a short-term period (180–545 days) (OR = 0.88, 95% CI = 0.81–0.86, <i>p</i> = 0.002; OR = 0.78, 95% CI = 0.66–0.92, <i>p</i> = 0.004; and OR = 0.91, 95% CI = 0.84–0.99, <i>p</i> = 0.039, respectively) compared to the control group. Hydrophilic statin use for 180–545 days was associated with 53% lower overall mortality (OR = 0.47; 95% CI = 0.29–0.77). In subgroup analyses, beneficial effects on both cancer development and mortality persisted in patients ≥65 years old, patients with normal blood pressure, and patients with high fasting glucose levels. There were no such associations with long-term statin use (&gt;545 days). Thus, the current nationwide cohort study suggests that prior short-term statin use may have anti-gastric cancer benefits in elderly patients with hyperglycemia. Full article </div> </div> <div > (This article belongs to the Special Issue Statins Use and Cancer) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 970 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study <div > by Romain Galy, <span ><div >Stéphanie Ballereau</div>, </span><span ><div >Yves Génisson</div>, </span><span ><div >Lionel Mourey</div>, </span>Jean-Christophe Plaquevent and <span ><div >Laurent Maveyraud</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1282; https://doi.org/10.3390/ph14121282 - 08 Dec 2021 </div> <div > Abstract <div > The mycolic acid biosynthetic pathway represents a promising source of pharmacological targets in the fight against tuberculosis. In <i>Mycobacterium tuberculosis</i>, mycolic acids are subject to specific chemical modifications introduced by a set of eight S-adenosylmethionine dependent methyltransferases. Among these, Hma (MmaA4) is [...] Read more. </div> <div > The mycolic acid biosynthetic pathway represents a promising source of pharmacological targets in the fight against tuberculosis. In <i>Mycobacterium tuberculosis</i>, mycolic acids are subject to specific chemical modifications introduced by a set of eight S-adenosylmethionine dependent methyltransferases. Among these, Hma (MmaA4) is responsible for the introduction of oxygenated modifications. Crystallographic screening of a library of fragments allowed the identification of seven ligands of Hma. Two mutually exclusive binding modes were identified, depending on the conformation of residues 147–154. These residues are disordered in <i>apo</i>-Hma but fold upon binding of the S-adenosylmethionine (SAM) cofactor as well as of analogues, resulting in the formation of the short η1-helix. One of the observed conformations would be incompatible with the presence of the cofactor, suggesting that allosteric inhibitors could be designed against Hma. Chimeric compounds were designed by fusing some of the bound fragments, and the relative binding affinities of initial fragments and evolved compounds were investigated using molecular dynamics simulation and generalised Born and Poisson–Boltzmann calculations coupled to the surface area continuum solvation method. Molecular dynamics simulations were also performed on <i>apo</i>-Hma to assess the structural plasticity of the unliganded protein. Our results indicate a significant improvement in the binding properties of the designed compounds, suggesting that they could be further optimised to inhibit Hma activity. Full article </div> </div> <div > (This article belongs to the Special Issue In Silico Approaches in Drug Design) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Green-Synthesized Magnesium Hydroxide Nanoparticles Induced Osteoblastic Differentiation in Bone Co-Cultured Cells <div > by <span ><div >Laura Costa Pinho</div>, </span><span ><div >Marta M. Alves</div>, </span><span ><div >Bruno Colaço</div>, </span><span ><div >Maria Helena Fernandes</div> and </span><span ><div >Catarina Santos</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1281; https://doi.org/10.3390/ph14121281 - 08 Dec 2021 </div> <div > Abstract <div > In this work, magnesium hydroxide NPs were synthesized using water (Mg(OH)<sub>2</sub> NPs) or a rose hip (RH) extract (Mg(OH)<sub>2</sub>RH NPs) and tested for the bone cells’ effects in co-cultured osteoblastic and osteoclastic cells, using a Transwell<sup>®</sup> insert system, allowing [...] Read more. </div> <div > In this work, magnesium hydroxide NPs were synthesized using water (Mg(OH)<sub>2</sub> NPs) or a rose hip (RH) extract (Mg(OH)<sub>2</sub>RH NPs) and tested for the bone cells’ effects in co-cultured osteoblastic and osteoclastic cells, using a Transwell<sup>®</sup> insert system, allowing reciprocal cell paracrine interactions. Behavior of each cell population was characterized for typical phenotype markers, at days 1 and 6. Cell cultures treated with osteogenic/osteoclastogenic inducers were used as positive control of cell differentiation. The NPs presented a round shape morphology with an average diameter ~90 nm (Mg(OH)<sub>2</sub> NPs) and below 10 nm (Mg(OH)<sub>2</sub>RH NPs. Both NPs induced osteoblastic and osteoclastic behavior similarly to that observed in induced osteoblastic and osteoclastic cultures (positive controls). Differences between the two types of particles were evident at the gene expression level. Compared to Mg(OH)<sub>2</sub> NPs, the green-synthesized NPs greatly increased the expression of osteoblastic genes coding for the early markers ALP and collagen type 1 and the later transcription factor osterix, while decreasing the expression of osteoclastogenic genes, namely the essential transcription factor NFATC1, TRAP and the genes coding for the functional markers CA2 and CTSK. Overall, a positive added effect could be hypothesized for Mg(OH)<sub>2</sub>RH NPs with potential usefulness to promote bone formation in regenerative applications. Full article </div> </div> <div > (This article belongs to the Special Issue Synthesis of Metal Nanoparticles and Their Pharmaceutical Applications) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 160 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessSystematic Review</div> Adipose Tissue-Derived Mesenchymal Stem Cells as a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis <div > by <span ><div >Henry Yue-Hong Meng</div>, </span><span ><div >Victor Lu</div> and </span><span ><div >Wasim Khan</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1280; https://doi.org/10.3390/ph14121280 - 08 Dec 2021 </div> <div > Abstract <div > Cartilage defects are a predisposing factor for osteoarthritis. Conventional therapies are mostly palliative and there is an interest in developing newer therapies that target the disease’s progression. Mesenchymal stem cells (MSCs) have been suggested as a promising therapy to restore hyaline cartilage to [...] Read more. </div> <div > Cartilage defects are a predisposing factor for osteoarthritis. Conventional therapies are mostly palliative and there is an interest in developing newer therapies that target the disease’s progression. Mesenchymal stem cells (MSCs) have been suggested as a promising therapy to restore hyaline cartilage to cartilage defects, though the optimal cell source has remained under investigation. A PRISMA systematic review was conducted utilising five databases (MEDLINE, EMBASE, Cochrane Library, Scopus, Web of Science) which identified nineteen human studies that used adipose tissue-derived MSC (AMSC)-based therapies, including culture-expanded AMSCs and stromal vascular fraction, to treat cartilage defects. Clinical, imaging and histological outcomes, as well as other relevant details pertaining to cartilage regeneration, were extracted from each study. Pooled analysis revealed a significant improvement in WOMAC scores (mean difference: −25.52; 95%CI (−30.93, −20.10); <i>p</i> &lt; 0.001), VAS scores (mean difference: −3.30; 95%CI (−3.72, −2.89); <i>p</i> &lt; 0.001), KOOS scores and end point MOCART score (mean: 68.12; 95%CI (62.18, 74.05)), thus showing improvement. The studies in this review demonstrate the safety and efficacy of AMSC-based therapies for cartilage defects. Establishing standardised methods for MSC extraction and delivery, and performing studies with long follow-up should enable future high-quality research to provide the evidence needed to bring AMSC-based therapies into the market. Full article </div> </div> <div > (This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose <div > by <span ><div >Matthew S. Ellis</div>, </span><span ><div >Zachary A. Kasper</div>, </span><span ><div >Mark Gold</div> and </span><span ><div >Theodore J. Cicero</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1279; https://doi.org/10.3390/ph14121279 - 08 Dec 2021 </div> <div > Abstract <div > While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified. However, there is little data in assessing the relationship between risk factor prevalence, associated provider communication, and subsequent perceptions of [...] Read more. </div> <div > While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified. However, there is little data in assessing the relationship between risk factor prevalence, associated provider communication, and subsequent perceptions of overdose risk among chronic pain, opioid-managed (CPOM) patients. An online questionnaire was distributed in June 2020 to a sample of CPOM individuals (n = 190) treated with an opioid prescription at or above 50 daily MME, or any dosage alongside benzodiazepines. CPOM individuals reported a mean daily MME of 470, with half (52.6%) receiving a concurrent benzodiazepine prescription. All patients reported past month alcohol use, and 67.4% indicated a risk-elevating diagnosed medical condition. In assessing provider communication, 41.6% reported no discussion focusing on the risks of one’s opioid therapy. Subsequently, 62.1% perceived themselves as having “no risk”, and 60.0% were “not at all concerned” (60.0%) about experiencing an opioid overdose. Organizational policies should focus on implementing consistent methods of patient education regarding overdose risk, as well as assessments of behaviors or characteristics that my increase an individual’s risk of opioid overdose. These policies should also include other forms of evidence-based overdose risk prevention such as co-prescriptions of naloxone. Full article </div> </div> <div > (This article belongs to the Special Issue Medicinal Chemistry and Pharmacological Activities of Opioid Drugs) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessConference Report</div> 29th Annual GP2A Medicinal Chemistry Conference <div > by <span ><div >Jean-Jacques Helesbeux</div>, </span><span ><div >Laura Carro</div>, </span><span ><div >Florence O. McCarthy</div>, </span><span ><div >Vânia M. Moreira</div>, </span><span ><div >Francesca Giuntini</div>, </span><span ><div >Niamh O’Boyle</div>, </span><span ><div >Susan E. Matthews</div>, </span><span ><div >Gülşah Bayraktar</div>, </span><span ><div >Samuel Bertrand</div>, </span><span ><div >Christophe Rochais</div> and </span><span ><div >Pascal Marchand</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1278; https://doi.org/10.3390/ph14121278 - 07 Dec 2021 </div> <div > Abstract <div > The 29th Annual GP<sub>2</sub>A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021. The meeting brought together [...] Read more. </div> <div > The 29th Annual GP<sub>2</sub>A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021. The meeting brought together an international delegation of researchers with interests in medicinal chemistry and interfacing disciplines. Abstracts of keynote lectures given by the 10 invited speakers, along with those of the 8 young researcher talks and the 50 flash presentation posters, are included in this report. Like previous editions, the conference was a real success, with high-level scientific discussions on cutting-edge advances in the fields of pharmaceutical chemistry. Full article </div> </div> <div > (This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> A Deep-Learning Proteomic-Scale Approach for Drug Design <div > by <span ><div >Brennan Overhoff</div>, </span><span ><div >Zackary Falls</div>, </span><span ><div >William Mangione</div> and </span><span ><div >Ram Samudrala</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1277; https://doi.org/10.3390/ph14121277 - 07 Dec 2021 </div> <div > Abstract <div > Computational approaches have accelerated novel therapeutic discovery in recent decades. The Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun multitarget therapeutic discovery, repurposing, and design aims to improve their efficacy and safety by employing a holistic approach that computes interaction signatures [...] Read more. </div> <div > Computational approaches have accelerated novel therapeutic discovery in recent decades. The Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun multitarget therapeutic discovery, repurposing, and design aims to improve their efficacy and safety by employing a holistic approach that computes interaction signatures between every drug/compound and a large library of non-redundant protein structures corresponding to the human proteome fold space. These signatures are compared and analyzed to determine if a given drug/compound is efficacious and safe for a given indication/disease. In this study, we used a deep learning-based autoencoder to first reduce the dimensionality of CANDO-computed drug–proteome interaction signatures. We then employed a reduced conditional variational autoencoder to generate novel drug-like compounds when given a target encoded “objective” signature. Using this approach, we designed compounds to recreate the interaction signatures for twenty approved and experimental drugs and showed that 16/20 designed compounds were predicted to be significantly (<i>p</i>-value ≤ 0.05) more behaviorally similar relative to all corresponding controls, and 20/20 were predicted to be more behaviorally similar relative to a random control. We further observed that redesigns of objectives developed via rational drug design performed significantly better than those derived from natural sources (<i>p</i>-value ≤ 0.05), suggesting that the model learned an abstraction of rational drug design. We also show that the designed compounds are structurally diverse and synthetically feasible when compared to their respective objective drugs despite consistently high predicted behavioral similarity. Finally, we generated new designs that enhanced thirteen drugs/compounds associated with non-small cell lung cancer and anti-aging properties using their predicted proteomic interaction signatures. his study represents a significant step forward in automating holistic therapeutic design with machine learning, enabling the rapid generation of novel, effective, and safe drug leads for any indication. Full article </div> </div> <div > (This article belongs to the Special Issue In Silico Approaches in Drug Design) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol <div > by <span ><div >Monika Skrzypiec-Spring</div>, </span><span ><div >Joanna Urbaniak</div>, </span><span ><div >Agnieszka Sapa-Wojciechowska</div>, </span><span ><div >Jadwiga Pietkiewicz</div>, </span><span ><div >Alina Orda</div>, </span><span ><div >Bożena Karolko</div>, </span><span ><div >Regina Danielewicz</div>, </span><span ><div >Iwona Bil-Lula</div>, </span><span ><div >Mieczysław Woźniak</div>, </span><span ><div >Richard Schulz</div> and </span><span ><div >Adam Szeląg</div></span> </div> <div > Pharmaceuticals <b>2021</b>, 14(12), 1276; https://doi.org/10.3390/ph14121276 - 07 Dec 2021 </div> <div > Abstract <div > Matrix metalloproteinase 2 (MMP-2) is activated in hearts upon ischemia-reperfusion (IR) injury and cleaves sarcomeric proteins. It was shown that carvedilol and nebivolol reduced the activity of different MMPs. Hence, we hypothesized that they could reduce MMPs activation in myocytes, and therefore, protect [...] Read more. </div> <div > Matrix metalloproteinase 2 (MMP-2) is activated in hearts upon ischemia-reperfusion (IR) injury and cleaves sarcomeric proteins. It was shown that carvedilol and nebivolol reduced the activity of different MMPs. Hence, we hypothesized that they could reduce MMPs activation in myocytes, and therefore, protect against cardiac contractile dysfunction related with IR injury. Isolated rat hearts were subjected to either control aerobic perfusion or IR injury: 25 min of aerobic perfusion, followed by 20 min global, no-flow ischemia, and reperfusion for 30 min. The effects of carvedilol, nebivolol, or metoprolol were evaluated in hearts subjected to IR injury. Cardiac mechanical function and MMP-2 activity in the heart homogenates and coronary effluent were assessed along with troponin I content in the former. Only carvedilol improved the recovery of mechanical function at the end of reperfusion compared to IR injury hearts. IR injury induced the activation and release of MMP-2 into the coronary effluent during reperfusion. MMP-2 activity in the coronary effluent increased in the IR injury group and this was prevented by carvedilol. Troponin I levels decreased by 73% in IR hearts and this was abolished by carvedilol. Conclusions: These data suggest that the cardioprotective effect of carvedilol in myocardial IR injury may be mediated by inhibiting MMP-2 activation. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>Pharmaceuticals</i> </a> Review for Pharmaceuticals <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > Pharmaceuticals Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Society Collaborations </li> <li > Conferences </li> <li > Editorial Office </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 14 (2021) </li> <li > Vol. 13 (2020) </li> <li > Vol. 12 (2019) </li> <li > Vol. 11 (2018) </li> <li > Vol. 10 (2017) </li> <li > Vol. 9 (2016) </li> <li > Vol. 8 (2015) </li> <li > Vol. 7 (2014) </li> <li > Vol. 6 (2013) </li> <li > Vol. 5 (2012) </li> <li > Vol. 4 (2011) </li> <li > Vol. 3 (2010) </li> <li > Vol. 2 (2009) </li> <li > Vol. 1 (2004) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > 26 October 2021 Journal of Nanotheranostics | JNT 2022 Travel Awards—Open for Application </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in Viruses, Biomedicines, Pharmaceuticals, Pharmaceutics, COVID</div> Broad-Spectrum Antiviral Agents Editors-in-Chief: Cheng-Wen Lin, Szu-Hao KungDeadline: 31 December 2021</div> <div ><div> Topic in Molecules, Toxics, Pharmaceuticals, BioMed</div> Development of Protective Therapies Facing Toxic Environmental Exposures Editors-in-Chief: Ricardo Lagoa, Mário DinizDeadline: 31 March 2022</div> <div ><div> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div ><div> Topic in Biomedicines, CIMB, IJMS, Neurology International, Pharmaceuticals</div> Neuroprotection by Drugs, Nutraceuticals and Physical Activity Editors-in-Chief: Cristina Angeloni, Andrea TarozziDeadline: 30 September 2022</div> <div > More Topics </div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 6–9 September 2022 The 4th ISFMS: Biochemistry, Molecular Biology and Druggability of Proteins</div> <div > 13–17 December 2021 Antibody Engineering Therapeutics 2021</div> <div > 19–22 January 2022 Joint 14th National Organic Chemistry Meeting (14ENQO) and 7th National Medicinal Chemistry Meeting (7ENQT)</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in Pharmaceuticals</div> Epigenetic Drugs Guest Editor: Marcin RatajewskiDeadline: 15 December 2021</div> <div ><div> Special Issue in Pharmaceuticals</div> Selective Chelators for Metals on Cells and Cancer Chemotherapy Guest Editor: Luís M. T. FrijaDeadline: 31 December 2021</div> <div ><div> Special Issue in Pharmaceuticals</div> Cancer Translational Biomarkers and Targeted Therapies Guest Editors: Raquel Lima, Marcelo CorreiaDeadline: 15 January 2022</div> <div ><div> Special Issue in Pharmaceuticals</div> GPCRs: Ligands and beyond 2022 Guest Editors: Erika Cione, Maria Cristina CaroleoDeadline: 20 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in Pharmaceuticals</div> The Story of Successful Drugs and Recent FDA-Approved Molecules Collection Editors: Jean Jacques Vanden Eynde, Klaus Kopka, Maria Emília de Sousa, Annie Mayence, Joachim Jose, Guangshun Wang</div> <div ><div> Topical Collection in Pharmaceuticals</div> Old Pharmaceuticals with New Applications Collection Editor: Maria Emília de Sousa</div> <div ><div> Topical Collection in Pharmaceuticals</div> Protein Kinases and Cancer Collection Editors: Khalil Ahmed, Janeen Trembley</div> <div ><div> Topical Collection in Pharmaceuticals</div> New Tools for Medicinal Chemists Collection Editors: Jean Jacques Vanden Eynde, Annie Mayence</div> </div> </div> <div > <div > <h2>Conference Reports</h2> </div> <div > <div ><div > 29th Annual GP2A Medicinal Chemistry Conference </div> Pharmaceuticals <b>2021</b>, 14(12), 1278; https://doi.org/10.3390/ph14121278 </div> <div ><div > 27th Annual GP2A Medicinal Chemistry Conference </div> Pharmaceuticals <b>2019</b>, 12(4), 179; https://doi.org/10.3390/ph12040179 </div> <div > More Conference Reports... </div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > Pharmaceuticals, EISSN 1424-8247, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Pharmaceuticals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> <a > Article Processing Charges </a> <a > Pay an Invoice </a> <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 5.863 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> Pharmaceuticals </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <ul class="valid" valid="valid" title="valid: True, node: 161, tag: ul, level: 9" node_number="161"> <li class="valid" valid="valid" title="valid: True, node: 162, tag: li, level: 10" node_number="162"> <a class="valid" valid="valid" title="valid: True, node: 163, tag: a, level: 11" node_number="163"> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"> Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge&#8212;Cell Binding Correlation </div> </a> </li> </ul> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 165, tag: div, level: 7" node_number="165"> <div class="valid" valid="valid" title="valid: True, node: 166, tag: div, level: 8" node_number="166"> <h2 class="valid" valid="valid" title="valid: True, node: 167, tag: h2, level: 9" node_number="167">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 168, tag: div, level: 8" node_number="168"> <div class="valid" valid="valid" title="valid: True, node: 169, tag: div, level: 9" node_number="169"> <h1 class="valid" valid="valid" title="valid: True, node: 170, tag: h1, level: 10" node_number="170"> Pharmaceuticals </h1> <div class="valid" valid="valid" title="valid: True, node: 171, tag: div, level: 10" node_number="171"> Pharmaceuticals is a <a class="valid" valid="valid" title="valid: True, node: 172, tag: a, level: 11" node_number="172">peer-reviewed</a>, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI.&#160;The <a class="valid" valid="valid" title="valid: True, node: 173, tag: a, level: 11" node_number="173">Academy of Pharmaceutical Sciences (APS)</a> is partners of Pharmaceuticals and their members receive a discount on the article processing charge. <ul class="valid" valid="valid" title="valid: True, node: 174, tag: ul, level: 11" node_number="174"> <li class="valid" valid="valid" title="valid: True, node: 175, tag: li, level: 12" node_number="175">Open Access&#8212; free for readers, with <a class="valid" valid="valid" title="valid: True, node: 176, tag: a, level: 13" node_number="176">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 177, tag: li, level: 12" node_number="177">High Visibility:&#160;indexed within <a class="valid" valid="valid" title="valid: True, node: 178, tag: a, level: 13" node_number="178">Scopus</a>, <a class="valid" valid="valid" title="valid: True, node: 179, tag: a, level: 13" node_number="179">SCIE&#160;(Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 180, tag: a, level: 13" node_number="180">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 181, tag: a, level: 13" node_number="181">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 182, tag: a, level: 13" node_number="182">Embase</a>, <a class="valid" valid="valid" title="valid: True, node: 183, tag: a, level: 13" node_number="183">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 184, tag: a, level: 13" node_number="184">other databases</a>.&#160;</li> <li class="valid" valid="valid" title="valid: True, node: 185, tag: li, level: 12" node_number="185">Journal Rank:&#160;JCR&#160;- Q1 (Pharmacology Pharmacy) /&#160;CiteScore&#160;- Q2 (Pharmaceutical Science)</li> <li class="valid" valid="valid" title="valid: True, node: 186, tag: li, level: 12" node_number="186">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.7 days after submission; acceptance to publication is undertaken in 3.4 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 187, tag: li, level: 12" node_number="187">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li class="valid" valid="valid" title="valid: True, node: 188, tag: li, level: 12" node_number="188">Testimonials: See what our authors say about Pharmaceuticals</li> <li class="valid" valid="valid" title="valid: True, node: 189, tag: li, level: 12" node_number="189">International Electronic Conference on Medicinal Chemistry (<a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 13" node_number="190">https://sciforum.net/series/ecmc/latest</a>)</li> <li class="valid" valid="valid" title="valid: True, node: 191, tag: li, level: 12" node_number="191">Companion journals for&#160;Pharmaceuticals include: <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 13" node_number="192">Pharmacoepidemiology</a> and <a class="valid" valid="valid" title="valid: True, node: 193, tag: a, level: 13" node_number="193">Psychoactives</a>.</li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 194, tag: div, level: 10" node_number="194"> Impact Factor: 5.863 (2020) ; 5-Year Impact Factor: 5.85 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 195, tag: div, level: 10" node_number="195"> <a class="valid" valid="valid" title="valid: True, node: 196, tag: a, level: 11" node_number="196"> <i class="valid" valid="valid" title="valid: True, node: 197, tag: i, level: 12" node_number="197">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 198, tag: a, level: 11" node_number="198"> <i class="valid" valid="valid" title="valid: True, node: 199, tag: i, level: 12" node_number="199">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 200, tag: a, level: 11" node_number="200"> Open Access </a> ISSN: 1424-8247 </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 201, tag: div, level: 7" node_number="201"> <div class="valid" valid="valid" title="valid: True, node: 202, tag: div, level: 8" node_number="202"> <h2 class="valid" valid="valid" title="valid: True, node: 203, tag: h2, level: 9" node_number="203">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 204, tag: div, level: 8" node_number="204"> <div class="valid" valid="valid" title="valid: True, node: 205, tag: div, level: 9" node_number="205"> <div class="valid" valid="valid" title="valid: True, node: 206, tag: div, level: 10" node_number="206"> <div class="valid" valid="valid" title="valid: True, node: 207, tag: div, level: 11" node_number="207"> <div class="valid" valid="valid" title="valid: True, node: 208, tag: div, level: 12" node_number="208"> <a class="valid" valid="valid" title="valid: True, node: 209, tag: a, level: 13" node_number="209"> <i class="valid" valid="valid" title="valid: True, node: 210, tag: i, level: 14" node_number="210">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 211, tag: div, level: 13" node_number="211"> Supplementary material: <a class="valid" valid="valid" title="valid: True, node: 212, tag: a, level: 14" node_number="212"> Supplementary File 1 (ZIP, 1102 KiB) </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 213, tag: div, level: 12" node_number="213"> <a class="valid" valid="valid" title="valid: True, node: 214, tag: a, level: 13" node_number="214"> <i class="valid" valid="valid" title="valid: True, node: 215, tag: i, level: 14" node_number="215">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 216, tag: div, level: 12" node_number="216"> <a class="valid" valid="valid" title="valid: True, node: 217, tag: a, level: 13" node_number="217"> <i class="valid" valid="valid" title="valid: True, node: 218, tag: i, level: 14" node_number="218">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 219, tag: div, level: 13" node_number="219"> View online as: <a class="valid" valid="valid" title="valid: True, node: 220, tag: a, level: 14" node_number="220">Abstract Page</a> <a class="valid" valid="valid" title="valid: True, node: 221, tag: a, level: 14" node_number="221">Full-Text HTML</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 222, tag: div, level: 12" node_number="222">Open AccessArticle</div> Graphene Oxide-Gold Nanorods Nanocomposite-Porphyrin Conjugate as Promising Tool for Cancer Phototherapy Performance <div class="valid" valid="valid" title="valid: True, node: 223, tag: div, level: 12" node_number="223"> by <span class="valid" valid="valid" title="valid: True, node: 224, tag: span, level: 13" node_number="224"><div class="valid" valid="valid" title="valid: True, node: 225, tag: div, level: 14" node_number="225">Thabang Calvin Lebepe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 226, tag: span, level: 13" node_number="226"><div class="valid" valid="valid" title="valid: True, node: 227, tag: div, level: 14" node_number="227">Sundararajan Parani</div>, </span><span class="valid" valid="valid" title="valid: True, node: 228, tag: span, level: 13" node_number="228"><div class="valid" valid="valid" title="valid: True, node: 229, tag: div, level: 14" node_number="229">Vuyelwa Ncapayi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 230, tag: span, level: 13" node_number="230"><div class="valid" valid="valid" title="valid: True, node: 231, tag: div, level: 14" node_number="231">Rodney Maluleke</div>, </span><span class="valid" valid="valid" title="valid: True, node: 232, tag: span, level: 13" node_number="232"><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233">Grace It Mwad Mbaz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 234, tag: span, level: 13" node_number="234"><div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 14" node_number="235">Olufunto Tolulope Fanoro</div>, </span><span class="valid" valid="valid" title="valid: True, node: 236, tag: span, level: 13" node_number="236"><div class="valid" valid="valid" title="valid: True, node: 237, tag: div, level: 14" node_number="237">Jose Rajendran Varghese</div>, </span><span class="valid" valid="valid" title="valid: True, node: 238, tag: span, level: 13" node_number="238"><div class="valid" valid="valid" title="valid: True, node: 239, tag: div, level: 14" node_number="239">Atsuki Komiya</div>, </span><span class="valid" valid="valid" title="valid: True, node: 240, tag: span, level: 13" node_number="240"><div class="valid" valid="valid" title="valid: True, node: 241, tag: div, level: 14" node_number="241">Tetsuya Kodama</div> and </span><span class="valid" valid="valid" title="valid: True, node: 242, tag: span, level: 13" node_number="242"><div class="valid" valid="valid" title="valid: True, node: 243, tag: div, level: 14" node_number="243">Oluwatobi Samuel Oluwafemi</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 244, tag: div, level: 12" node_number="244"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 245, tag: b, level: 13" node_number="245">2021</b>, 14(12), 1295; https://doi.org/10.3390/ph14121295 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 12" node_number="246"> Abstract <div class="valid" valid="valid" title="valid: True, node: 247, tag: div, level: 13" node_number="247"> The cancer mortality rate has increased, and conventional cancer treatments are known for having many side effects. Therefore, it is imperative to find a new therapeutic agent or modify the existing therapeutic agents for better performance and efficiency. Herein, a synergetic phototherapeutic agent [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 248, tag: div, level: 13" node_number="248"> The cancer mortality rate has increased, and conventional cancer treatments are known for having many side effects. Therefore, it is imperative to find a new therapeutic agent or modify the existing therapeutic agents for better performance and efficiency. Herein, a synergetic phototherapeutic agent based on a combination of photothermal and photodynamic therapy is proposed. The phototherapeutic agent consists of water-soluble cationic porphyrin (5,10,15,20-tetrakis(<i class="valid" valid="valid" title="valid: True, node: 249, tag: i, level: 14" node_number="249">N</i>-methylpyridinium-3-yl)porphyrin, TMePyP), and gold nanorods (AuNRs) anchored on graphene-oxide (GO) sheet. The TMePyP was initially synthesized by Adler method, followed by methylation, while GO and AuNRs were synthesized using Hummer&#8217;s and seed-mediated methods, respectively. The structural and optical properties of TMePyP were confirmed using UV-Vis, zeta analyzer, PL, FTIR and NMR. The formation of both GO and AuNRs was confirmed by UV-Vis-NIR, FTIR, TEM and zeta analyzer. TMePyP and AuNRs were anchored on GO to form [email&#160;protected] nanocomposite. The as-synthesized nanocomposite was stable in RPMI and PBS medium, and, on irradiation, produced high heat than the bare AuNRs, with high photothermal efficiency. In addition, the nanocomposite produced higher singlet oxygen than TMePyP with high biocompatibility in the absence of light. These results indicated that the as-synthesized nanocomposite is a promising dual photodynamic and photothermal agent for cancer therapy. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 250, tag: div, level: 12" node_number="250"> (This article belongs to the Special Issue Synthesis of Metal Nanoparticles and Their Pharmaceutical Applications) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 251, tag: div, level: 12" node_number="251"><div class="valid" valid="valid" title="valid: True, node: 252, tag: div, level: 13" node_number="252"><div class="valid" valid="valid" title="valid: True, node: 253, tag: div, level: 14" node_number="253"><p title="valid: False, node: 254, tag: p, level: 15" node_number="254">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 255, tag: div, level: 9" node_number="255"> <div class="valid" valid="valid" title="valid: True, node: 256, tag: div, level: 10" node_number="256"> <div class="valid" valid="valid" title="valid: True, node: 257, tag: div, level: 11" node_number="257"> <div class="valid" valid="valid" title="valid: True, node: 258, tag: div, level: 12" node_number="258"> <div class="valid" valid="valid" title="valid: True, node: 259, tag: div, level: 13" node_number="259"> <a class="valid" valid="valid" title="valid: True, node: 260, tag: a, level: 14" node_number="260"> <i title="valid: False, node: 261, tag: i, level: 15" node_number="261">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 262, tag: div, level: 13" node_number="262"> <a class="valid" valid="valid" title="valid: True, node: 263, tag: a, level: 14" node_number="263"> <i title="valid: False, node: 264, tag: i, level: 15" node_number="264">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 265, tag: div, level: 14" node_number="265"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 266, tag: div, level: 13" node_number="266">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 267, tag: a, level: 13" node_number="267">Evaluation of Amebicidal and Cysticidal Activities of Antifungal Drug Isavuconazonium Sulfate against <i class="valid" valid="valid" title="valid: True, node: 268, tag: i, level: 14" node_number="268">Acanthamoeba</i> T4 Strains</a> <div class="valid" valid="valid" title="valid: True, node: 269, tag: div, level: 13" node_number="269"> by <span class="valid" valid="valid" title="valid: True, node: 270, tag: span, level: 14" node_number="270"><div title="valid: False, node: 271, tag: div, level: 15" node_number="271">Brian Shing</div>, </span><span class="valid" valid="valid" title="valid: True, node: 272, tag: span, level: 14" node_number="272"><div title="valid: False, node: 273, tag: div, level: 15" node_number="273">Mina Balen</div> and </span><span class="valid" valid="valid" title="valid: True, node: 274, tag: span, level: 14" node_number="274"><div title="valid: False, node: 275, tag: div, level: 15" node_number="275">Anjan Debnath</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 276, tag: div, level: 13" node_number="276"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 277, tag: b, level: 14" node_number="277">2021</b>, 14(12), 1294; https://doi.org/10.3390/ph14121294 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 278, tag: div, level: 13" node_number="278"> Abstract <div class="valid" valid="valid" title="valid: True, node: 279, tag: div, level: 14" node_number="279"> <i title="valid: False, node: 280, tag: i, level: 15" node_number="280">Acanthamoeba</i> species of amebae are often associated with <i title="valid: False, node: 281, tag: i, level: 15" node_number="281">Acanthamoeba</i> keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized into the active isavuconazole moiety. Isavuconazole was previously identified to have [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 282, tag: div, level: 14" node_number="282"> <i title="valid: False, node: 283, tag: i, level: 15" node_number="283">Acanthamoeba</i> species of amebae are often associated with <i title="valid: False, node: 284, tag: i, level: 15" node_number="284">Acanthamoeba</i> keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized into the active isavuconazole moiety. Isavuconazole was previously identified to have amebicidal and cysticidal activity against <i title="valid: False, node: 285, tag: i, level: 15" node_number="285">Acanthamoeba</i> T4 strains, but the activity of its prodrug, isavuconazonium sulfate, against trophozoites and cysts remains unknown. Since it is not known if isavuconazonium can be metabolized into isavuconazole in the human eye, we evaluated the activities of isavuconazonium sulfate against trophozoites and cysts of three T4 genotype strains of <i title="valid: False, node: 286, tag: i, level: 15" node_number="286">Acanthamoeba.</i> Isavuconazonium displayed amebicidal activity at nanomolar concentrations as low as 1.4 nM and prevented excystation of cysts at concentrations as low as 136 &#956;M. We also investigated the cysticidal activity of isavuconazonium sulfate in combination with a currently used amebicidal drug polyhexamethylene biguanide (PHMB). Although combination of isavuconazonium with PHMB did not elicit an obvious synergistic cysticidal activity, the combination did not cause an antagonistic effect on the cysts of <i title="valid: False, node: 287, tag: i, level: 15" node_number="287">Acanthamoeba</i> T4 strains. Collectively, these findings suggest isavuconazonium retains potency against <i title="valid: False, node: 288, tag: i, level: 15" node_number="288">Acanthamoeba</i> T4 strains and could be adapted for <i title="valid: False, node: 289, tag: i, level: 15" node_number="289">Acanthamoeba</i> keratitis treatment. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 290, tag: div, level: 13" node_number="290"> (This article belongs to the Special Issue Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 291, tag: div, level: 13" node_number="291"><div class="valid" valid="valid" title="valid: True, node: 292, tag: div, level: 14" node_number="292"><div title="valid: False, node: 293, tag: div, level: 15" node_number="293"><p title="valid: False, node: 294, tag: p, level: 16" node_number="294">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 295, tag: div, level: 10" node_number="295"> <div class="valid" valid="valid" title="valid: True, node: 296, tag: div, level: 11" node_number="296"> <div class="valid" valid="valid" title="valid: True, node: 297, tag: div, level: 12" node_number="297"> <div class="valid" valid="valid" title="valid: True, node: 298, tag: div, level: 13" node_number="298"> <a class="valid" valid="valid" title="valid: True, node: 299, tag: a, level: 14" node_number="299"> <i title="valid: False, node: 300, tag: i, level: 15" node_number="300">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 301, tag: div, level: 13" node_number="301"> <a class="valid" valid="valid" title="valid: True, node: 302, tag: a, level: 14" node_number="302"> <i title="valid: False, node: 303, tag: i, level: 15" node_number="303">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 304, tag: div, level: 14" node_number="304"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 305, tag: div, level: 13" node_number="305">Open AccessArticle</div> Lichen-Derived Compounds and Extracts as Biologically Active Substances with Anticancer and Neuroprotective Properties <div class="valid" valid="valid" title="valid: True, node: 306, tag: div, level: 13" node_number="306"> by <span class="valid" valid="valid" title="valid: True, node: 307, tag: span, level: 14" node_number="307"><div title="valid: False, node: 308, tag: div, level: 15" node_number="308">El&#380;bieta Studzi&#324;ska-Sroka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 309, tag: span, level: 14" node_number="309"><div title="valid: False, node: 310, tag: div, level: 15" node_number="310">Aleksandra Majchrzak-Celi&#324;ska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 311, tag: span, level: 14" node_number="311"><div title="valid: False, node: 312, tag: div, level: 15" node_number="312">Przemys&#322;aw Zalewski</div>, </span><span class="valid" valid="valid" title="valid: True, node: 313, tag: span, level: 14" node_number="313"><div title="valid: False, node: 314, tag: div, level: 15" node_number="314">Dominik Szwajgier</div>, </span><span class="valid" valid="valid" title="valid: True, node: 315, tag: span, level: 14" node_number="315"><div title="valid: False, node: 316, tag: div, level: 15" node_number="316">Ewa Baranowska-W&#243;jcik</div>, </span><span class="valid" valid="valid" title="valid: True, node: 317, tag: span, level: 14" node_number="317"><div title="valid: False, node: 318, tag: div, level: 15" node_number="318">Barbara Kapro&#324;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 319, tag: span, level: 14" node_number="319"><div title="valid: False, node: 320, tag: div, level: 15" node_number="320">Tomasz Plech</div>, </span><span class="valid" valid="valid" title="valid: True, node: 321, tag: span, level: 14" node_number="321"><div title="valid: False, node: 322, tag: div, level: 15" node_number="322">Marcin &#379;arowski</div> and </span><span class="valid" valid="valid" title="valid: True, node: 323, tag: span, level: 14" node_number="323"><div title="valid: False, node: 324, tag: div, level: 15" node_number="324">Judyta Cielecka-Piontek</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 325, tag: div, level: 13" node_number="325"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 326, tag: b, level: 14" node_number="326">2021</b>, 14(12), 1293; https://doi.org/10.3390/ph14121293 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 327, tag: div, level: 13" node_number="327"> Abstract <div class="valid" valid="valid" title="valid: True, node: 328, tag: div, level: 14" node_number="328"> Lichens are a source of chemical compounds with valuable biological properties, structurally predisposed to penetration into the central nervous system (CNS). Hence, our research aimed to examine the biological potential of lipophilic extracts of <i title="valid: False, node: 329, tag: i, level: 15" node_number="329">Parmelia sulcata</i>, <i title="valid: False, node: 330, tag: i, level: 15" node_number="330">Evernia prunastri</i>, <i title="valid: False, node: 331, tag: i, level: 15" node_number="331">Cladonia uncialis</i>, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 332, tag: div, level: 14" node_number="332"> Lichens are a source of chemical compounds with valuable biological properties, structurally predisposed to penetration into the central nervous system (CNS). Hence, our research aimed to examine the biological potential of lipophilic extracts of <i title="valid: False, node: 333, tag: i, level: 15" node_number="333">Parmelia sulcata</i>, <i title="valid: False, node: 334, tag: i, level: 15" node_number="334">Evernia prunastri</i>, <i title="valid: False, node: 335, tag: i, level: 15" node_number="335">Cladonia uncialis</i>, and their major secondary metabolites, in the context of searching for new therapies for CNS diseases, mainly glioblastoma multiforme (GBM). The extracts selected for the study were standardized for their content of salazinic acid, evernic acid, and (&#8722;)-usnic acid, respectively. The extracts and lichen metabolites were evaluated in terms of their anti-tumor activity, i.e. cytotoxicity against A-172 and T98G cell lines and anti-IDO1, IDO2, TDO activity, their anti-inflammatory properties exerted by anti-COX-2 and anti-hyaluronidase activity, antioxidant activity, and anti-acetylcholinesterase and anti-butyrylcholinesterase activity. The results of this study indicate that lichen-derived compounds and extracts exert significant cytotoxicity against GBM cells, inhibit the kynurenine pathway enzymes, and have anti-inflammatory properties and weak antioxidant and anti-cholinesterase properties. Moreover, evernic acid and (&#8722;)-usnic acid were shown to be able to cross the blood-brain barrier. These results demonstrate that lichen-derived extracts and compounds, especially (&#8722;)-usnic acid, can be regarded as prototypes of pharmacologically active compounds within the CNS, especially suitable for the treatment of GBM. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 336, tag: div, level: 13" node_number="336"> (This article belongs to the Special Issue Plant and Marine-Derived Natural Product Research in Drug Discovery: Strengths and Perspective) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 337, tag: div, level: 13" node_number="337"><div class="valid" valid="valid" title="valid: True, node: 338, tag: div, level: 14" node_number="338"><div title="valid: False, node: 339, tag: div, level: 15" node_number="339"><p title="valid: False, node: 340, tag: p, level: 16" node_number="340">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 341, tag: div, level: 10" node_number="341"> <div class="valid" valid="valid" title="valid: True, node: 342, tag: div, level: 11" node_number="342"> <div class="valid" valid="valid" title="valid: True, node: 343, tag: div, level: 12" node_number="343"> <div class="valid" valid="valid" title="valid: True, node: 344, tag: div, level: 13" node_number="344"> <a class="valid" valid="valid" title="valid: True, node: 345, tag: a, level: 14" node_number="345"> <i title="valid: False, node: 346, tag: i, level: 15" node_number="346">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 347, tag: div, level: 14" node_number="347"> Supplementary material: Supplementary File 1 (ZIP, 12627 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 348, tag: div, level: 13" node_number="348"> <a class="valid" valid="valid" title="valid: True, node: 349, tag: a, level: 14" node_number="349"> <i title="valid: False, node: 350, tag: i, level: 15" node_number="350">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 351, tag: div, level: 13" node_number="351"> <a class="valid" valid="valid" title="valid: True, node: 352, tag: a, level: 14" node_number="352"> <i title="valid: False, node: 353, tag: i, level: 15" node_number="353">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 354, tag: div, level: 14" node_number="354"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 355, tag: div, level: 13" node_number="355">Open AccessArticle</div> Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein <div class="valid" valid="valid" title="valid: True, node: 356, tag: div, level: 13" node_number="356"> by <span class="valid" valid="valid" title="valid: True, node: 357, tag: span, level: 14" node_number="357"><div title="valid: False, node: 358, tag: div, level: 15" node_number="358">Anunay J. Pulukuri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 359, tag: span, level: 14" node_number="359"><div title="valid: False, node: 360, tag: div, level: 15" node_number="360">Anthony J. Burt</div>, </span><span class="valid" valid="valid" title="valid: True, node: 361, tag: span, level: 14" node_number="361"><div title="valid: False, node: 362, tag: div, level: 15" node_number="362">Larissa K. Opp</div>, </span><span class="valid" valid="valid" title="valid: True, node: 363, tag: span, level: 14" node_number="363"><div title="valid: False, node: 364, tag: div, level: 15" node_number="364">Colin M. McDowell</div>, </span><span class="valid" valid="valid" title="valid: True, node: 365, tag: span, level: 14" node_number="365"><div title="valid: False, node: 366, tag: div, level: 15" node_number="366">Maryam Davaritouchaee</div>, </span><span class="valid" valid="valid" title="valid: True, node: 367, tag: span, level: 14" node_number="367"><div title="valid: False, node: 368, tag: div, level: 15" node_number="368">Amy E. Nielsen</div> and </span><span class="valid" valid="valid" title="valid: True, node: 369, tag: span, level: 14" node_number="369"><div title="valid: False, node: 370, tag: div, level: 15" node_number="370">Rock J. Mancini</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 371, tag: div, level: 13" node_number="371"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 372, tag: b, level: 14" node_number="372">2021</b>, 14(12), 1292; https://doi.org/10.3390/ph14121292 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 373, tag: div, level: 13" node_number="373"> Abstract <div class="valid" valid="valid" title="valid: True, node: 374, tag: div, level: 14" node_number="374"> Multidrug-Resistant (MDR) cancers attenuate chemotherapeutic efficacy through drug efflux, a process that transports drugs from within a cell to the extracellular space via ABC (ATP-Binding Cassette) transporters, including P-glycoprotein 1 (P-gp or ABCB1/MDR1). Conversely, Toll-Like Receptor (TLR) agonist immunotherapies modulate activity of tumor-infiltrating [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 375, tag: div, level: 14" node_number="375"> Multidrug-Resistant (MDR) cancers attenuate chemotherapeutic efficacy through drug efflux, a process that transports drugs from within a cell to the extracellular space via ABC (ATP-Binding Cassette) transporters, including P-glycoprotein 1 (P-gp or ABCB1/MDR1). Conversely, Toll-Like Receptor (TLR) agonist immunotherapies modulate activity of tumor-infiltrating immune cells in local proximity to cancer cells and could, therefore, benefit from the enhanced drug efflux in MDR cancers. However, the effect of acquired drug resistance on TLR agonist efflux is largely unknown. We begin to address this by investigating P-gp mediated efflux of TLR 7/8 agonists. First, we used functionalized liposomes to determine that imidazoquinoline TLR agonists Imiquimod, Resiquimod, and Gardiquimod are substrates for P-gp. Interestingly, the least potent imidazoquinoline (Imiquimod) was the best P-gp substrate. Next, we compared imidazoquinoline efflux in MDR cancer cell lines with enhanced P-gp expression relative to parent cancer cell lines. Using P-gp competitive substrates and inhibitors, we observed that imidazoquinoline efflux occurs through P-gp and, for Imiquimod, is enhanced as a consequence of acquired drug resistance. This suggests that enhancing efflux susceptibility could be an important consideration in the rational design of next generation immunotherapies that modulate activity of tumor-infiltrating immune cells. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 376, tag: div, level: 13" node_number="376"> (This article belongs to the Special Issue Anticancer Drugs 2021) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 377, tag: div, level: 13" node_number="377"><div class="valid" valid="valid" title="valid: True, node: 378, tag: div, level: 14" node_number="378"><div title="valid: False, node: 379, tag: div, level: 15" node_number="379"><p title="valid: False, node: 380, tag: p, level: 16" node_number="380">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 381, tag: div, level: 10" node_number="381"> <div class="valid" valid="valid" title="valid: True, node: 382, tag: div, level: 11" node_number="382"> <div class="valid" valid="valid" title="valid: True, node: 383, tag: div, level: 12" node_number="383"> <div class="valid" valid="valid" title="valid: True, node: 384, tag: div, level: 13" node_number="384"> <a class="valid" valid="valid" title="valid: True, node: 385, tag: a, level: 14" node_number="385"> <i title="valid: False, node: 386, tag: i, level: 15" node_number="386">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 387, tag: div, level: 14" node_number="387"> Supplementary material: Supplementary File 1 (ZIP, 19073 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 388, tag: div, level: 13" node_number="388"> <a class="valid" valid="valid" title="valid: True, node: 389, tag: a, level: 14" node_number="389"> <i title="valid: False, node: 390, tag: i, level: 15" node_number="390">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 391, tag: div, level: 13" node_number="391"> <a class="valid" valid="valid" title="valid: True, node: 392, tag: a, level: 14" node_number="392"> <i title="valid: False, node: 393, tag: i, level: 15" node_number="393">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 394, tag: div, level: 14" node_number="394"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 395, tag: div, level: 13" node_number="395">Open AccessArticle</div> Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II&#8212;Design, Synthesis, and Evaluation <div class="valid" valid="valid" title="valid: True, node: 396, tag: div, level: 13" node_number="396"> by <span class="valid" valid="valid" title="valid: True, node: 397, tag: span, level: 14" node_number="397"><div title="valid: False, node: 398, tag: div, level: 15" node_number="398">Michal Mary&#353;ka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 399, tag: span, level: 14" node_number="399"><div title="valid: False, node: 400, tag: div, level: 15" node_number="400">Lucie Svobodov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 401, tag: span, level: 14" node_number="401"><div title="valid: False, node: 402, tag: div, level: 15" node_number="402">Wim Dehaen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 403, tag: span, level: 14" node_number="403"><div title="valid: False, node: 404, tag: div, level: 15" node_number="404">Martina Hrabinov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 405, tag: span, level: 14" node_number="405"><div title="valid: False, node: 406, tag: div, level: 15" node_number="406">Michaela Rumlov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 407, tag: span, level: 14" node_number="407"><div title="valid: False, node: 408, tag: div, level: 15" node_number="408">Ond&#345;ej Soukup</div> and </span><span class="valid" valid="valid" title="valid: True, node: 409, tag: span, level: 14" node_number="409"><div title="valid: False, node: 410, tag: div, level: 15" node_number="410">Martin Kucha&#345;</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 411, tag: div, level: 13" node_number="411"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 412, tag: b, level: 14" node_number="412">2021</b>, 14(12), 1291; https://doi.org/10.3390/ph14121291 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 413, tag: div, level: 13" node_number="413"> Abstract <div class="valid" valid="valid" title="valid: True, node: 414, tag: div, level: 14" node_number="414"> Kynurenic acid is a neuroprotective metabolite of tryptophan formed by kynurenine aminotransferase (KAT) catalyzed transformation of kynurenine. However, its high brain levels are associated with cognitive deficit and with the pathophysiology of schizophrenia. Although several classes of KAT inhibitors have been published, the [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 415, tag: div, level: 14" node_number="415"> Kynurenic acid is a neuroprotective metabolite of tryptophan formed by kynurenine aminotransferase (KAT) catalyzed transformation of kynurenine. However, its high brain levels are associated with cognitive deficit and with the pathophysiology of schizophrenia. Although several classes of KAT inhibitors have been published, the search for new inhibitor chemotypes is crucial for the process of finding suitable clinical candidates. Therefore, we used pharmacophore modeling and molecular docking, which predicted derivatives of heterocyclic amino ketones as new potential irreversible inhibitors of kynurenine aminotransferase II. Thiazole and triazole-based amino ketones were synthesized within a SAR study and their inhibitory activities were evaluated in vitro. The observed activities confirmed our computational model and, moreover, the best compounds showed sub-micromolar inhibitory activity with 2-alaninoyl-5-(4-fluorophenyl)thiazole having IC<sub title="valid: False, node: 416, tag: sub, level: 15" node_number="416">50</sub> = 0.097 &#181;M. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 417, tag: div, level: 13" node_number="417"> (This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 418, tag: div, level: 13" node_number="418"><div class="valid" valid="valid" title="valid: True, node: 419, tag: div, level: 14" node_number="419"><div title="valid: False, node: 420, tag: div, level: 15" node_number="420"><p title="valid: False, node: 421, tag: p, level: 16" node_number="421">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 422, tag: div, level: 10" node_number="422"> <div class="valid" valid="valid" title="valid: True, node: 423, tag: div, level: 11" node_number="423"> <div class="valid" valid="valid" title="valid: True, node: 424, tag: div, level: 12" node_number="424"> <div class="valid" valid="valid" title="valid: True, node: 425, tag: div, level: 13" node_number="425"> <a class="valid" valid="valid" title="valid: True, node: 426, tag: a, level: 14" node_number="426"> <i title="valid: False, node: 427, tag: i, level: 15" node_number="427">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 428, tag: div, level: 14" node_number="428"> Supplementary material: Supplementary File 1 (ZIP, 19030 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 429, tag: div, level: 13" node_number="429"> <a class="valid" valid="valid" title="valid: True, node: 430, tag: a, level: 14" node_number="430"> <i title="valid: False, node: 431, tag: i, level: 15" node_number="431">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 432, tag: div, level: 13" node_number="432"> <a class="valid" valid="valid" title="valid: True, node: 433, tag: a, level: 14" node_number="433"> <i title="valid: False, node: 434, tag: i, level: 15" node_number="434">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 435, tag: div, level: 14" node_number="435"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 436, tag: div, level: 13" node_number="436">Open AccessArticle</div> Discovery of a Novel Template, 7-Substituted 7-Deaza-4&#8242;-Thioadenosine Derivatives as Multi-Kinase Inhibitors <div class="valid" valid="valid" title="valid: True, node: 437, tag: div, level: 13" node_number="437"> by <span class="valid" valid="valid" title="valid: True, node: 438, tag: span, level: 14" node_number="438"><div title="valid: False, node: 439, tag: div, level: 15" node_number="439">Karishma K. Mashelkar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 440, tag: span, level: 14" node_number="440"><div title="valid: False, node: 441, tag: div, level: 15" node_number="441">Woong Sub Byun</div>, </span><span class="valid" valid="valid" title="valid: True, node: 442, tag: span, level: 14" node_number="442"><div title="valid: False, node: 443, tag: div, level: 15" node_number="443">Hyejin Ko</div>, </span><span class="valid" valid="valid" title="valid: True, node: 444, tag: span, level: 14" node_number="444"><div title="valid: False, node: 445, tag: div, level: 15" node_number="445">Kisu Sung</div>, </span><span class="valid" valid="valid" title="valid: True, node: 446, tag: span, level: 14" node_number="446"><div title="valid: False, node: 447, tag: div, level: 15" node_number="447">Sushil K. Tripathi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 448, tag: span, level: 14" node_number="448"><div title="valid: False, node: 449, tag: div, level: 15" node_number="449">Seungchan An</div>, </span><span class="valid" valid="valid" title="valid: True, node: 450, tag: span, level: 14" node_number="450"><div title="valid: False, node: 451, tag: div, level: 15" node_number="451">Yun A Yum</div>, </span><span class="valid" valid="valid" title="valid: True, node: 452, tag: span, level: 14" node_number="452"><div title="valid: False, node: 453, tag: div, level: 15" node_number="453">Jee Youn Kwon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 454, tag: span, level: 14" node_number="454"><div title="valid: False, node: 455, tag: div, level: 15" node_number="455">Minjae Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 456, tag: span, level: 14" node_number="456"><div title="valid: False, node: 457, tag: div, level: 15" node_number="457">Gibae Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 458, tag: span, level: 14" node_number="458"><div title="valid: False, node: 459, tag: div, level: 15" node_number="459">Eun-Ji Kwon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 460, tag: span, level: 14" node_number="460"><div title="valid: False, node: 461, tag: div, level: 15" node_number="461">Hyuk Woo Lee</div>, </span><span class="valid" valid="valid" title="valid: True, node: 462, tag: span, level: 14" node_number="462"><div title="valid: False, node: 463, tag: div, level: 15" node_number="463">Minsoo Noh</div>, </span><span class="valid" valid="valid" title="valid: True, node: 464, tag: span, level: 14" node_number="464"><div title="valid: False, node: 465, tag: div, level: 15" node_number="465">Sang Kook Lee</div> and </span><span class="valid" valid="valid" title="valid: True, node: 466, tag: span, level: 14" node_number="466"><div title="valid: False, node: 467, tag: div, level: 15" node_number="467">Lak Shin Jeong</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 468, tag: div, level: 13" node_number="468"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 469, tag: b, level: 14" node_number="469">2021</b>, 14(12), 1290; https://doi.org/10.3390/ph14121290 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 470, tag: div, level: 13" node_number="470"> Abstract <div class="valid" valid="valid" title="valid: True, node: 471, tag: div, level: 14" node_number="471"> The development of anticancer drugs remains challenging owing to the potential for drug resistance. The simultaneous inhibition of multiple targets involved in cancer could overcome resistance, and these agents would exhibit higher potency than single-target inhibitors. Protein kinases represent a promising target for [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 472, tag: div, level: 14" node_number="472"> The development of anticancer drugs remains challenging owing to the potential for drug resistance. The simultaneous inhibition of multiple targets involved in cancer could overcome resistance, and these agents would exhibit higher potency than single-target inhibitors. Protein kinases represent a promising target for the development of anticancer agents. As most multi-kinase inhibitors are heterocycles occupying only the hinge and hydrophobic region in the ATP binding site, we aimed to design multi-kinase inhibitors that would occupy the ribose pocket, along with the hinge and hydrophobic region, based on ATP-kinase interactions. Herein, we report the discovery of a novel 4&#8242;-thionucleoside template as a multi-kinase inhibitor with potent anticancer activity. The in vitro evaluation revealed a lead <b title="valid: False, node: 473, tag: b, level: 15" node_number="473">1g</b> (7-acetylene-7-deaza-4&#8242;-thioadenosine) with potent anticancer activity, and marked inhibition of TRKA, CK1&#948;, and DYRK1A/1B kinases in the kinome scan assay. We believe that these findings will pave the way for developing anticancer drugs. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 474, tag: div, level: 13" node_number="474"> (This article belongs to the Special Issue Anticancer Drugs 2021) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 475, tag: div, level: 13" node_number="475"><div class="valid" valid="valid" title="valid: True, node: 476, tag: div, level: 14" node_number="476"><div title="valid: False, node: 477, tag: div, level: 15" node_number="477"><p title="valid: False, node: 478, tag: p, level: 16" node_number="478">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 479, tag: div, level: 10" node_number="479"> <div class="valid" valid="valid" title="valid: True, node: 480, tag: div, level: 11" node_number="480"> <div class="valid" valid="valid" title="valid: True, node: 481, tag: div, level: 12" node_number="481"> <div class="valid" valid="valid" title="valid: True, node: 482, tag: div, level: 13" node_number="482"> <a class="valid" valid="valid" title="valid: True, node: 483, tag: a, level: 14" node_number="483"> <i title="valid: False, node: 484, tag: i, level: 15" node_number="484">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 485, tag: div, level: 14" node_number="485"> Supplementary material: Supplementary File 1 (ZIP, 2056 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 13" node_number="486"> <a class="valid" valid="valid" title="valid: True, node: 487, tag: a, level: 14" node_number="487"> <i title="valid: False, node: 488, tag: i, level: 15" node_number="488">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 13" node_number="489"> <a class="valid" valid="valid" title="valid: True, node: 490, tag: a, level: 14" node_number="490"> <i title="valid: False, node: 491, tag: i, level: 15" node_number="491">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 492, tag: div, level: 14" node_number="492"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 493, tag: div, level: 13" node_number="493">Open AccessArticle</div> From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes <div class="valid" valid="valid" title="valid: True, node: 494, tag: div, level: 13" node_number="494"> by <span class="valid" valid="valid" title="valid: True, node: 495, tag: span, level: 14" node_number="495"><div title="valid: False, node: 496, tag: div, level: 15" node_number="496">Giuseppe Floresta</div>, </span><span class="valid" valid="valid" title="valid: True, node: 497, tag: span, level: 14" node_number="497"><div title="valid: False, node: 498, tag: div, level: 15" node_number="498">Antonino Nicol&#242; Fallica</div>, </span><span class="valid" valid="valid" title="valid: True, node: 499, tag: span, level: 14" node_number="499"><div title="valid: False, node: 500, tag: div, level: 15" node_number="500">Vincenzo Patamia</div>, </span><span class="valid" valid="valid" title="valid: True, node: 501, tag: span, level: 14" node_number="501"><div title="valid: False, node: 502, tag: div, level: 15" node_number="502">Valeria Sorrenti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 503, tag: span, level: 14" node_number="503"><div title="valid: False, node: 504, tag: div, level: 15" node_number="504">Khaled Greish</div>, </span><span class="valid" valid="valid" title="valid: True, node: 505, tag: span, level: 14" node_number="505"><div title="valid: False, node: 506, tag: div, level: 15" node_number="506">Antonio Rescifina</div> and </span><span class="valid" valid="valid" title="valid: True, node: 507, tag: span, level: 14" node_number="507"><div title="valid: False, node: 508, tag: div, level: 15" node_number="508">Valeria Pittal&#224;</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 509, tag: div, level: 13" node_number="509"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 510, tag: b, level: 14" node_number="510">2021</b>, 14(12), 1289; https://doi.org/10.3390/ph14121289 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 511, tag: div, level: 13" node_number="511"> Abstract <div class="valid" valid="valid" title="valid: True, node: 512, tag: div, level: 14" node_number="512"> HO-1 overexpression has been reported in several cases/types of human malignancies. Unfortunately, poor clinical outcomes are reported in most of these cases, and the inhibition of HO-1 is considered a valuable and proven anticancer approach. To identify novel hit compounds suitable as HO-1 [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 513, tag: div, level: 14" node_number="513"> HO-1 overexpression has been reported in several cases/types of human malignancies. Unfortunately, poor clinical outcomes are reported in most of these cases, and the inhibition of HO-1 is considered a valuable and proven anticancer approach. To identify novel hit compounds suitable as HO-1 inhibitors, we report here a fragment-based approach where ligand joining experiments were used. The two most important parts of the classical structure of the HO-1 inhibitors were used as a starting point, and 1000 novel compounds were generated and then virtually evaluated by structure and ligand-based approaches. The joining experiments led us to a novel series of indole-based compounds. A synthetic pathway for eight selected molecules was designed, and the compounds were synthesized. The biological activity revealed that some molecules reach the micromolar activity, whereas molecule <b title="valid: False, node: 514, tag: b, level: 15" node_number="514">4d</b> inhibits the HO-1 with an IC<sub title="valid: False, node: 515, tag: sub, level: 15" node_number="515">50</sub> of 1.03 &#956;M. This study suggested that our joining approach was successful, and a novel hit compound was generated. These results are ongoing for further development. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 516, tag: div, level: 13" node_number="516"> (This article belongs to the Section Medicinal Chemistry) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 517, tag: div, level: 13" node_number="517"><div class="valid" valid="valid" title="valid: True, node: 518, tag: div, level: 14" node_number="518"><div title="valid: False, node: 519, tag: div, level: 15" node_number="519"><p title="valid: False, node: 520, tag: p, level: 16" node_number="520">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 521, tag: div, level: 10" node_number="521"> <div class="valid" valid="valid" title="valid: True, node: 522, tag: div, level: 11" node_number="522"> <div class="valid" valid="valid" title="valid: True, node: 523, tag: div, level: 12" node_number="523"> <div class="valid" valid="valid" title="valid: True, node: 524, tag: div, level: 13" node_number="524"> <a class="valid" valid="valid" title="valid: True, node: 525, tag: a, level: 14" node_number="525"> <i title="valid: False, node: 526, tag: i, level: 15" node_number="526">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 527, tag: div, level: 13" node_number="527"> <a class="valid" valid="valid" title="valid: True, node: 528, tag: a, level: 14" node_number="528"> <i title="valid: False, node: 529, tag: i, level: 15" node_number="529">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 530, tag: div, level: 14" node_number="530"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 531, tag: div, level: 13" node_number="531">Open AccessOpinion</div> A New Paradigm to Indicate Antidepressant Treatments <div class="valid" valid="valid" title="valid: True, node: 532, tag: div, level: 13" node_number="532"> by <span class="valid" valid="valid" title="valid: True, node: 533, tag: span, level: 14" node_number="533"><div title="valid: False, node: 534, tag: div, level: 15" node_number="534">Anton J. M. Loonen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 535, tag: span, level: 14" node_number="535"><div title="valid: False, node: 536, tag: div, level: 15" node_number="536">Taichi Ochi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 537, tag: span, level: 14" node_number="537"><div title="valid: False, node: 538, tag: div, level: 15" node_number="538">Lisanne M. Geers</div>, </span><span class="valid" valid="valid" title="valid: True, node: 539, tag: span, level: 14" node_number="539"><div title="valid: False, node: 540, tag: div, level: 15" node_number="540">German G. Simutkin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 541, tag: span, level: 14" node_number="541"><div title="valid: False, node: 542, tag: div, level: 15" node_number="542">Nikolay A. Bokhan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 543, tag: span, level: 14" node_number="543"><div title="valid: False, node: 544, tag: div, level: 15" node_number="544">Dani&#235;l J. Touw</div>, </span><span class="valid" valid="valid" title="valid: True, node: 545, tag: span, level: 14" node_number="545"><div title="valid: False, node: 546, tag: div, level: 15" node_number="546">Bob Wilffert</div>, </span><span class="valid" valid="valid" title="valid: True, node: 547, tag: span, level: 14" node_number="547"><div title="valid: False, node: 548, tag: div, level: 15" node_number="548">Alexander N. Kornetov</div> and </span><span class="valid" valid="valid" title="valid: True, node: 549, tag: span, level: 14" node_number="549"><div title="valid: False, node: 550, tag: div, level: 15" node_number="550">Svetlana A. Ivanova</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 551, tag: div, level: 13" node_number="551"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 552, tag: b, level: 14" node_number="552">2021</b>, 14(12), 1288; https://doi.org/10.3390/ph14121288 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 553, tag: div, level: 13" node_number="553"> Abstract <div class="valid" valid="valid" title="valid: True, node: 554, tag: div, level: 14" node_number="554"> This article develops the idea that clinical depression can be seen as a typical human response, largely rooted in human culture, to events of loss or times of adversity. Various biological, psychological, and social factors may cause some individuals to have a depressive [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 555, tag: div, level: 14" node_number="555"> This article develops the idea that clinical depression can be seen as a typical human response, largely rooted in human culture, to events of loss or times of adversity. Various biological, psychological, and social factors may cause some individuals to have a depressive reaction that is ineffectually limited in time and/or severity. Recovery occurs mainly based on natural resilience mechanisms, which come into play spontaneously, but which are sometimes inhibited or blocked by specific pathological biopsychosocial mechanisms. One of the mechanisms for this could be the influence of the circuits that regulate pleasure and happiness, along the dorsal diencephalic connection (DDC) pathway from the forebrain to the midbrain via the habenula. Therapy works by undermining the biopsychosocial factors that prevent the natural recovery mechanism from working. Treatment should, therefore, be seen as facilitating rather than causing natural recovery. This approach is in line with the high recovery rate after placebo treatments and the positive influence of pharmacological treatments with completely different sites of action. Acceptance of this model means that when studying new treatments for depression, a new paradigm must be applied in which the relative value of antidepressant treatment is specifically weighted in terms of enabling the natural resilience process. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 556, tag: div, level: 13" node_number="556"> (This article belongs to the Section Pharmacology) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 557, tag: div, level: 13" node_number="557"><div class="valid" valid="valid" title="valid: True, node: 558, tag: div, level: 14" node_number="558"><div title="valid: False, node: 559, tag: div, level: 15" node_number="559"><p title="valid: False, node: 560, tag: p, level: 16" node_number="560">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 561, tag: div, level: 10" node_number="561"> <div class="valid" valid="valid" title="valid: True, node: 562, tag: div, level: 11" node_number="562"> <div class="valid" valid="valid" title="valid: True, node: 563, tag: div, level: 12" node_number="563"> <div class="valid" valid="valid" title="valid: True, node: 564, tag: div, level: 13" node_number="564"> <a class="valid" valid="valid" title="valid: True, node: 565, tag: a, level: 14" node_number="565"> <i title="valid: False, node: 566, tag: i, level: 15" node_number="566">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 567, tag: div, level: 13" node_number="567"> <a class="valid" valid="valid" title="valid: True, node: 568, tag: a, level: 14" node_number="568"> <i title="valid: False, node: 569, tag: i, level: 15" node_number="569">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 570, tag: div, level: 14" node_number="570"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 571, tag: div, level: 13" node_number="571">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 572, tag: a, level: 13" node_number="572">Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal <i class="valid" valid="valid" title="valid: True, node: 573, tag: i, level: 14" node_number="573">SHP-1 </i>and<i class="valid" valid="valid" title="valid: True, node: 574, tag: i, level: 14" node_number="574"> SOCS-3 </i>Hypermethylation: In Vitro and In Silico Evaluation</a> <div class="valid" valid="valid" title="valid: True, node: 575, tag: div, level: 13" node_number="575"> by <span class="valid" valid="valid" title="valid: True, node: 576, tag: span, level: 14" node_number="576"><div title="valid: False, node: 577, tag: div, level: 15" node_number="577">Futoon Abedrabbu Al-Rawashde</div>, </span><span class="valid" valid="valid" title="valid: True, node: 578, tag: span, level: 14" node_number="578"><div title="valid: False, node: 579, tag: div, level: 15" node_number="579">Muhammad Farid Johan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 580, tag: span, level: 14" node_number="580"><div title="valid: False, node: 581, tag: div, level: 15" node_number="581">Wan Rohani Wan Taib</div>, </span><span class="valid" valid="valid" title="valid: True, node: 582, tag: span, level: 14" node_number="582"><div title="valid: False, node: 583, tag: div, level: 15" node_number="583">Imilia Ismail</div>, </span><span class="valid" valid="valid" title="valid: True, node: 584, tag: span, level: 14" node_number="584"><div title="valid: False, node: 585, tag: div, level: 15" node_number="585">Syed Ahmad Tajudin Tuan Johari</div>, </span><span class="valid" valid="valid" title="valid: True, node: 586, tag: span, level: 14" node_number="586"><div title="valid: False, node: 587, tag: div, level: 15" node_number="587">Belal Almajali</div>, </span><span class="valid" valid="valid" title="valid: True, node: 588, tag: span, level: 14" node_number="588"><div title="valid: False, node: 589, tag: div, level: 15" node_number="589">Abdullah Saleh Al-wajeeh</div>, </span><span class="valid" valid="valid" title="valid: True, node: 590, tag: span, level: 14" node_number="590"><div title="valid: False, node: 591, tag: div, level: 15" node_number="591">Mansoureh Nazari V.</div> and </span><span class="valid" valid="valid" title="valid: True, node: 592, tag: span, level: 14" node_number="592"><div title="valid: False, node: 593, tag: div, level: 15" node_number="593">Hamid Ali Nagi Al-Jamal</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 594, tag: div, level: 13" node_number="594"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 595, tag: b, level: 14" node_number="595">2021</b>, 14(12), 1287; https://doi.org/10.3390/ph14121287 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 596, tag: div, level: 13" node_number="596"> Abstract <div class="valid" valid="valid" title="valid: True, node: 597, tag: div, level: 14" node_number="597"> Epigenetic silencing of tumor suppressor genes (TSGs) plays an essential role in cancer pathogenesis, including acute myeloid leukemia (AML). All of<i title="valid: False, node: 598, tag: i, level: 15" node_number="598"> SHP-1</i>, <i title="valid: False, node: 599, tag: i, level: 15" node_number="599">SOCS-1</i>, and<i title="valid: False, node: 600, tag: i, level: 15" node_number="600"> SOCS-3</i> are TSGs that negatively regulate JAK/STAT signaling. Enhanced re-expression of TSGs through de-methylation represents a therapeutic [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 601, tag: div, level: 14" node_number="601"> Epigenetic silencing of tumor suppressor genes (TSGs) plays an essential role in cancer pathogenesis, including acute myeloid leukemia (AML). All of<i title="valid: False, node: 602, tag: i, level: 15" node_number="602"> SHP-1</i>, <i title="valid: False, node: 603, tag: i, level: 15" node_number="603">SOCS-1</i>, and<i title="valid: False, node: 604, tag: i, level: 15" node_number="604"> SOCS-3</i> are TSGs that negatively regulate JAK/STAT signaling. Enhanced re-expression of TSGs through de-methylation represents a therapeutic target in several cancers. Thymoquinone (TQ) is a major component of <i title="valid: False, node: 605, tag: i, level: 15" node_number="605">Nigella sativa</i> seeds with anticancer effects against several cancers. However, the effects of TQ on DNA methylation are not entirely understood. This study aimed to evaluate the ability of TQ to re-express <i title="valid: False, node: 606, tag: i, level: 15" node_number="606">SHP-1</i>, <i title="valid: False, node: 607, tag: i, level: 15" node_number="607">SOCS-1</i>, and<i title="valid: False, node: 608, tag: i, level: 15" node_number="608"> SOCS-3</i> in MV4-11 AML cells through de-methylation. Cytotoxicity, apoptosis, and cell cycle assays were performed using WSTs-8 kit, Annexin V-FITC/PI apoptosis detection kit, and fluorometric-red cell cycle assay kit, respectively. The methylation of <i title="valid: False, node: 609, tag: i, level: 15" node_number="609">SHP-1</i>, <i title="valid: False, node: 610, tag: i, level: 15" node_number="610">SOCS-1</i>, and <i title="valid: False, node: 611, tag: i, level: 15" node_number="611">SOCS-3 </i>was evaluated by pyrosequencing analysis. The expression of<i title="valid: False, node: 612, tag: i, level: 15" node_number="612"> SHP-1</i>, <i title="valid: False, node: 613, tag: i, level: 15" node_number="613">SOCS-1</i>, <i title="valid: False, node: 614, tag: i, level: 15" node_number="614">SOCS-3</i>, <i title="valid: False, node: 615, tag: i, level: 15" node_number="615">JAK2</i>, <i title="valid: False, node: 616, tag: i, level: 15" node_number="616">STAT3</i>, <i title="valid: False, node: 617, tag: i, level: 15" node_number="617">STAT5A</i>, <i title="valid: False, node: 618, tag: i, level: 15" node_number="618">STAT5B</i>, <i title="valid: False, node: 619, tag: i, level: 15" node_number="619">FLT3</i>-ITD, <i title="valid: False, node: 620, tag: i, level: 15" node_number="620">DNMT1</i>, <i title="valid: False, node: 621, tag: i, level: 15" node_number="621">DNMT3A</i>, <i title="valid: False, node: 622, tag: i, level: 15" node_number="622">DNMT3B</i>,<i title="valid: False, node: 623, tag: i, level: 15" node_number="623"> TET2</i>, and<i title="valid: False, node: 624, tag: i, level: 15" node_number="624"> WT1</i> was assessed by RT-qPCR. The molecular docking of TQ to JAK2, STAT 3, and STAT5 was evaluated. The results revealed that TQ significantly inhibited the growth of MV4-11 cells and induced apoptosis in a dose- and time-dependent manner. Interestingly, the results showed that TQ binds the active pocket of JAK2, STAT3, and STAT5 to inhibit their enzymatic activity and significantly enhances the re-expression of <i title="valid: False, node: 625, tag: i, level: 15" node_number="625">SHP-1</i> and <i title="valid: False, node: 626, tag: i, level: 15" node_number="626">SOCS-3</i> through de-methylation. In conclusion, TQ curbs MV4-11 cells by inhibiting the enzymatic activity of JAK/STAT signaling through hypomethylation and re-expression of JAK/STAT negative regulators and could be a promising therapeutic candidate for AML patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 627, tag: div, level: 13" node_number="627"> (This article belongs to the Section Pharmacology) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 628, tag: div, level: 10" node_number="628"> <div class="valid" valid="valid" title="valid: True, node: 629, tag: div, level: 11" node_number="629"> <div class="valid" valid="valid" title="valid: True, node: 630, tag: div, level: 12" node_number="630"> <div class="valid" valid="valid" title="valid: True, node: 631, tag: div, level: 13" node_number="631"> <a class="valid" valid="valid" title="valid: True, node: 632, tag: a, level: 14" node_number="632"> <i title="valid: False, node: 633, tag: i, level: 15" node_number="633">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 634, tag: div, level: 13" node_number="634"> <a class="valid" valid="valid" title="valid: True, node: 635, tag: a, level: 14" node_number="635"> <i title="valid: False, node: 636, tag: i, level: 15" node_number="636">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 637, tag: div, level: 14" node_number="637"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 638, tag: div, level: 13" node_number="638">Open AccessReview</div> PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers <div class="valid" valid="valid" title="valid: True, node: 639, tag: div, level: 13" node_number="639"> by <span class="valid" valid="valid" title="valid: True, node: 640, tag: span, level: 14" node_number="640"><div title="valid: False, node: 641, tag: div, level: 15" node_number="641">Petar Saric</div>, </span><span class="valid" valid="valid" title="valid: True, node: 642, tag: span, level: 14" node_number="642"><div title="valid: False, node: 643, tag: div, level: 15" node_number="643">Kathleen A. Young</div>, </span><span class="valid" valid="valid" title="valid: True, node: 644, tag: span, level: 14" node_number="644"><div title="valid: False, node: 645, tag: div, level: 15" node_number="645">Martin Rodriguez-Porcel</div> and </span><span class="valid" valid="valid" title="valid: True, node: 646, tag: span, level: 14" node_number="646"><div title="valid: False, node: 647, tag: div, level: 15" node_number="647">Panithaya Chareonthaitawee</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 648, tag: div, level: 13" node_number="648"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 649, tag: b, level: 14" node_number="649">2021</b>, 14(12), 1286; https://doi.org/10.3390/ph14121286 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 650, tag: div, level: 13" node_number="650"> Abstract <div class="valid" valid="valid" title="valid: True, node: 651, tag: div, level: 14" node_number="651"> Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 652, tag: div, level: 14" node_number="652"> Sarcoidosis is a multi-system inflammatory disease characterized by the development of inflammation and noncaseating granulomas that can involve nearly every organ system, with a predilection for the pulmonary system. Cardiac involvement of sarcoidosis (CS) occurs in up to 70% of cases, and accounts for a significant share of sarcoid-related mortality. The clinical presentation of CS can range from absence of symptoms to conduction abnormalities, heart failure, arrhythmias, valvular disease, and sudden cardiac death. Given the significant morbidity and mortality associated with CS, timely diagnosis is important. Traditional imaging modalities and histologic evaluation by endomyocardial biopsy often provide a low diagnostic yield. Cardiac positron emission tomography (PET) has emerged as a leading advanced imaging modality for the diagnosis and management of CS. This review article will summarize several aspects of the current use of PET in CS, including indications for use, patient preparation, image acquisition and interpretation, diagnostic and prognostic performance, and evaluation of treatment response. Additionally, this review will discuss novel PET radiotracers currently under study or of potential interest in CS. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 653, tag: div, level: 13" node_number="653"> (This article belongs to the Special Issue Molecular Imaging for Cardiology: Radiopharmaceuticals for PET and SPECT) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 654, tag: div, level: 13" node_number="654"><div class="valid" valid="valid" title="valid: True, node: 655, tag: div, level: 14" node_number="655"><div title="valid: False, node: 656, tag: div, level: 15" node_number="656"><p title="valid: False, node: 657, tag: p, level: 16" node_number="657">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 658, tag: div, level: 10" node_number="658"> <div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 11" node_number="659"> <div class="valid" valid="valid" title="valid: True, node: 660, tag: div, level: 12" node_number="660"> <div class="valid" valid="valid" title="valid: True, node: 661, tag: div, level: 13" node_number="661"> <a class="valid" valid="valid" title="valid: True, node: 662, tag: a, level: 14" node_number="662"> <i title="valid: False, node: 663, tag: i, level: 15" node_number="663">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 664, tag: div, level: 13" node_number="664"> <a class="valid" valid="valid" title="valid: True, node: 665, tag: a, level: 14" node_number="665"> <i title="valid: False, node: 666, tag: i, level: 15" node_number="666">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 667, tag: div, level: 14" node_number="667"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 668, tag: div, level: 13" node_number="668">Open AccessArticle</div> Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational Approach <div class="valid" valid="valid" title="valid: True, node: 669, tag: div, level: 13" node_number="669"> by <span class="valid" valid="valid" title="valid: True, node: 670, tag: span, level: 14" node_number="670"><div title="valid: False, node: 671, tag: div, level: 15" node_number="671">Fatimawali</div>, </span><span class="valid" valid="valid" title="valid: True, node: 672, tag: span, level: 14" node_number="672"><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">Trina Ekawati Tallei</div>, </span><span class="valid" valid="valid" title="valid: True, node: 674, tag: span, level: 14" node_number="674"><div title="valid: False, node: 675, tag: div, level: 15" node_number="675">Billy Johnson Kepel</div>, </span><span class="valid" valid="valid" title="valid: True, node: 676, tag: span, level: 14" node_number="676"><div title="valid: False, node: 677, tag: div, level: 15" node_number="677">Mohammed Alorabi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 678, tag: span, level: 14" node_number="678"><div title="valid: False, node: 679, tag: div, level: 15" node_number="679">Ahmed M. El-Shehawi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 680, tag: span, level: 14" node_number="680"><div title="valid: False, node: 681, tag: div, level: 15" node_number="681">Widdhi Bodhi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 682, tag: span, level: 14" node_number="682"><div title="valid: False, node: 683, tag: div, level: 15" node_number="683">Sefren Geiner Tumilaar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 684, tag: span, level: 14" node_number="684"><div title="valid: False, node: 685, tag: div, level: 15" node_number="685">Ismail Celik</div>, </span><span class="valid" valid="valid" title="valid: True, node: 686, tag: span, level: 14" node_number="686"><div title="valid: False, node: 687, tag: div, level: 15" node_number="687">Gomaa Mostafa-Hedeab</div>, </span><span class="valid" valid="valid" title="valid: True, node: 688, tag: span, level: 14" node_number="688"><div title="valid: False, node: 689, tag: div, level: 15" node_number="689">Amany Abdel-Rahman Mohamed</div> and </span><span class="valid" valid="valid" title="valid: True, node: 690, tag: span, level: 14" node_number="690"><div title="valid: False, node: 691, tag: div, level: 15" node_number="691">Talha Bin Emran</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 692, tag: div, level: 13" node_number="692"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 693, tag: b, level: 14" node_number="693">2021</b>, 14(12), 1285; https://doi.org/10.3390/ph14121285 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 694, tag: div, level: 13" node_number="694"> Abstract <div class="valid" valid="valid" title="valid: True, node: 695, tag: div, level: 14" node_number="695"> In many countries, the fruit of betel (<i title="valid: False, node: 696, tag: i, level: 15" node_number="696">Piper betle</i> Linn) is traditionally used as medicine for treating malaria. It is a fatal disease, and existing medications are rapidly losing potency, necessitating the development of innovative pharmaceutics. The current study attempted to determine [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 697, tag: div, level: 14" node_number="697"> In many countries, the fruit of betel (<i title="valid: False, node: 698, tag: i, level: 15" node_number="698">Piper betle</i> Linn) is traditionally used as medicine for treating malaria. It is a fatal disease, and existing medications are rapidly losing potency, necessitating the development of innovative pharmaceutics. The current study attempted to determine the compounds in the n-hexane fraction of betel fruit extract and investigate the potential inhibition of bioactive compounds against aspartic protease plasmepsin 1 (PDB ID: 3QS1) and plasmepsin 2 (PDB ID: 1LEE) of <i title="valid: False, node: 699, tag: i, level: 15" node_number="699">Plasmodium falciparum</i> using a computational approach. The ethanol extract was fractionated into n-hexane and further analyzed using gas chromatography-mass spectrometry (GC-MS) to obtain information regarding the compounds contained in betel fruit. Each compound&#8217;s potential antimalarial activity was evaluated using AutoDock Vina and compared to artemisinin, an antimalarial drug. Molecular dynamics simulations (MDSs) were performed to evaluate the stability of the interaction between the ligand and receptors. Results detected 20 probable compounds in the n-hexane extract of betel fruit based on GC-MS analysis. The docking study revealed that androstan-17-one,3-ethyl-3-hydroxy-, (5 alpha)- has the highest binding affinity for plasmepsin 1 and plasmepsin 2. The compound exhibits a similar interaction with artemisinin at the active site of the receptors. The compound does not violate Lipinski&#8217;s rules of five. It belongs to class 5 toxicity with an LD<sub title="valid: False, node: 700, tag: sub, level: 15" node_number="700">50</sub> of 3000 mg/kg. MDS results showed stable interactions between the compound and the receptors. Our study concluded that androstan-17-one,3-ethyl-3-hydroxy-, (5 alpha)- from betel fruit has the potential to be further investigated as a potential inhibitor of the aspartic protease plasmepsin 1 and plasmepsin 2 of <i title="valid: False, node: 701, tag: i, level: 15" node_number="701">Plasmodium falciparum</i>. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 702, tag: div, level: 13" node_number="702"> (This article belongs to the Section Medicinal Chemistry) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 13" node_number="703"><div class="valid" valid="valid" title="valid: True, node: 704, tag: div, level: 14" node_number="704"><div title="valid: False, node: 705, tag: div, level: 15" node_number="705"><p title="valid: False, node: 706, tag: p, level: 16" node_number="706">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 707, tag: div, level: 10" node_number="707"> <div class="valid" valid="valid" title="valid: True, node: 708, tag: div, level: 11" node_number="708"> <div class="valid" valid="valid" title="valid: True, node: 709, tag: div, level: 12" node_number="709"> <div class="valid" valid="valid" title="valid: True, node: 710, tag: div, level: 13" node_number="710"> <a class="valid" valid="valid" title="valid: True, node: 711, tag: a, level: 14" node_number="711"> <i title="valid: False, node: 712, tag: i, level: 15" node_number="712">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 713, tag: div, level: 14" node_number="713"> Supplementary material: Supplementary File 1 (ZIP, 423 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 714, tag: div, level: 13" node_number="714"> <a class="valid" valid="valid" title="valid: True, node: 715, tag: a, level: 14" node_number="715"> <i title="valid: False, node: 716, tag: i, level: 15" node_number="716">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 717, tag: div, level: 13" node_number="717"> <a class="valid" valid="valid" title="valid: True, node: 718, tag: a, level: 14" node_number="718"> <i title="valid: False, node: 719, tag: i, level: 15" node_number="719">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 720, tag: div, level: 14" node_number="720"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 721, tag: div, level: 13" node_number="721">Open AccessArticle</div> New Method for the Monitoring of Antidepressants in Oral Fluid Using Dried Spot Sampling <div class="valid" valid="valid" title="valid: True, node: 722, tag: div, level: 13" node_number="722"> by <span class="valid" valid="valid" title="valid: True, node: 723, tag: span, level: 14" node_number="723"><div title="valid: False, node: 724, tag: div, level: 15" node_number="724">Sofia Soares</div>, </span><span class="valid" valid="valid" title="valid: True, node: 725, tag: span, level: 14" node_number="725"><div title="valid: False, node: 726, tag: div, level: 15" node_number="726">Tiago Rosado</div>, </span><span class="valid" valid="valid" title="valid: True, node: 727, tag: span, level: 14" node_number="727"><div title="valid: False, node: 728, tag: div, level: 15" node_number="728">M&#225;rio Barroso</div> and </span><span class="valid" valid="valid" title="valid: True, node: 729, tag: span, level: 14" node_number="729"><div title="valid: False, node: 730, tag: div, level: 15" node_number="730">Eugenia Gallardo</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 731, tag: div, level: 13" node_number="731"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 732, tag: b, level: 14" node_number="732">2021</b>, 14(12), 1284; https://doi.org/10.3390/ph14121284 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 733, tag: div, level: 13" node_number="733"> Abstract <div class="valid" valid="valid" title="valid: True, node: 734, tag: div, level: 14" node_number="734"> The increase in the consumption of antidepressants is a public health problem worldwide, as these are a class of compounds widely used in the treatment of several illnesses, such as depression and anxiety. This work aimed to develop and optimize a method for [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 735, tag: div, level: 14" node_number="735"> The increase in the consumption of antidepressants is a public health problem worldwide, as these are a class of compounds widely used in the treatment of several illnesses, such as depression and anxiety. This work aimed to develop and optimize a method for the quantification of a number of antidepressants and their metabolites (fluoxetine, venlafaxine, <i title="valid: False, node: 736, tag: i, level: 15" node_number="736">O</i>-desmethylvenlafaxine, citalopram, sertraline, and paroxetine) in 100 &#181;L of oral fluid using the dried saliva spots (DSS) sampling approach and gas chromatography coupled with tandem mass spectrometry (GC&#8211;MS/MS). The method was validated, presenting linearity within the studied range, with detection and quantification limits ranging between 10 and 100 ng/mL, and coefficients of determination (R<sup title="valid: False, node: 737, tag: sup, level: 15" node_number="737">2</sup>) of at least 0.99 for all analytes. Recoveries were between approximately 13 and 46%. The analysis of precision and accuracy presented acceptable coefficients of variation and relative errors, considering the criteria usually accepted in the validation of bioanalytical procedures. The method herein described is the first to be reported using DSS for the extraction of antidepressants, proving to be a sensitive, simple, and fast alternative to conventional techniques, and capable of being routinely applied in clinical and forensic toxicology scenarios. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 738, tag: div, level: 13" node_number="738"> (This article belongs to the Special Issue Analytical Techniques in the Pharmaceutical Sciences) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 739, tag: div, level: 13" node_number="739"><div class="valid" valid="valid" title="valid: True, node: 740, tag: div, level: 14" node_number="740"><div title="valid: False, node: 741, tag: div, level: 15" node_number="741"><p title="valid: False, node: 742, tag: p, level: 16" node_number="742">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 743, tag: div, level: 10" node_number="743"> <div class="valid" valid="valid" title="valid: True, node: 744, tag: div, level: 11" node_number="744"> <div class="valid" valid="valid" title="valid: True, node: 745, tag: div, level: 12" node_number="745"> <div class="valid" valid="valid" title="valid: True, node: 746, tag: div, level: 13" node_number="746"> <a class="valid" valid="valid" title="valid: True, node: 747, tag: a, level: 14" node_number="747"> <i title="valid: False, node: 748, tag: i, level: 15" node_number="748">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 749, tag: div, level: 14" node_number="749"> Supplementary material: Supplementary File 1 (ZIP, 3115 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 750, tag: div, level: 13" node_number="750"> <a class="valid" valid="valid" title="valid: True, node: 751, tag: a, level: 14" node_number="751"> <i title="valid: False, node: 752, tag: i, level: 15" node_number="752">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 753, tag: div, level: 13" node_number="753"> <a class="valid" valid="valid" title="valid: True, node: 754, tag: a, level: 14" node_number="754"> <i title="valid: False, node: 755, tag: i, level: 15" node_number="755">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 756, tag: div, level: 14" node_number="756"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 757, tag: div, level: 13" node_number="757">Open AccessArticle</div> Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea <div class="valid" valid="valid" title="valid: True, node: 758, tag: div, level: 13" node_number="758"> by <span class="valid" valid="valid" title="valid: True, node: 759, tag: span, level: 14" node_number="759"><div title="valid: False, node: 760, tag: div, level: 15" node_number="760">Mi Jung Kwon</div>, </span><span class="valid" valid="valid" title="valid: True, node: 761, tag: span, level: 14" node_number="761"><div title="valid: False, node: 762, tag: div, level: 15" node_number="762">Ho Suk Kang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 763, tag: span, level: 14" node_number="763"><div title="valid: False, node: 764, tag: div, level: 15" node_number="764">Joo-Hee Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 765, tag: span, level: 14" node_number="765"><div title="valid: False, node: 766, tag: div, level: 15" node_number="766">Ji Hee Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 767, tag: span, level: 14" node_number="767"><div title="valid: False, node: 768, tag: div, level: 15" node_number="768">Se Hoon Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 769, tag: span, level: 14" node_number="769"><div title="valid: False, node: 770, tag: div, level: 15" node_number="770">Nan Young Kim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 771, tag: span, level: 14" node_number="771"><div title="valid: False, node: 772, tag: div, level: 15" node_number="772">Eun Sook Nam</div>, </span><span class="valid" valid="valid" title="valid: True, node: 773, tag: span, level: 14" node_number="773"><div title="valid: False, node: 774, tag: div, level: 15" node_number="774">Kyueng-Whan Min</div> and </span><span class="valid" valid="valid" title="valid: True, node: 775, tag: span, level: 14" node_number="775"><div title="valid: False, node: 776, tag: div, level: 15" node_number="776">Hyo Geun Choi</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 777, tag: div, level: 13" node_number="777"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 778, tag: b, level: 14" node_number="778">2021</b>, 14(12), 1283; https://doi.org/10.3390/ph14121283 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 779, tag: div, level: 13" node_number="779"> Abstract <div class="valid" valid="valid" title="valid: True, node: 780, tag: div, level: 14" node_number="780"> Concerns about the hazards of statins on the development and mortality of stomach cancers remain controversial. Here, we investigated the likelihood of incident gastric cancers and related mortality depending on statin exposure, statin type, and the duration of use. This nested case&#8211;control-designed study [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 781, tag: div, level: 14" node_number="781"> Concerns about the hazards of statins on the development and mortality of stomach cancers remain controversial. Here, we investigated the likelihood of incident gastric cancers and related mortality depending on statin exposure, statin type, and the duration of use. This nested case&#8211;control-designed study was composed of 8798 patients who were diagnosed with gastric cancer and matched with 35,192 controls at a 1:4 ratio based on propensity scores of age, sex, residential area, and income from the Korean National Health Insurance Service&#8212;Health Screening Cohort database (2002&#8211;2015). Propensity score overlap weighting was adjusted to balance the baseline covariates. Overlap propensity score-weighted logistic regression analyses were assessed to determine associations of the prior use of statins (any statin, hydrophilic statins vs. lipophilic statins) with incident gastric cancer and its mortality depending on the medication duration (&lt;180 days, 180&#8211;545 days, and &gt;545 days) after adjusting for multiple covariates. After adjustment, the use of any statin, hydrophilic statins, or lipophilic statins showed significant associations with lower odds for incident stomach cancer when used for a short-term period (180&#8211;545 days) (OR = 0.88, 95% CI = 0.81&#8211;0.86, <i title="valid: False, node: 782, tag: i, level: 15" node_number="782">p</i> = 0.002; OR = 0.78, 95% CI = 0.66&#8211;0.92, <i title="valid: False, node: 783, tag: i, level: 15" node_number="783">p</i> = 0.004; and OR = 0.91, 95% CI = 0.84&#8211;0.99, <i title="valid: False, node: 784, tag: i, level: 15" node_number="784">p</i> = 0.039, respectively) compared to the control group. Hydrophilic statin use for 180&#8211;545 days was associated with 53% lower overall mortality (OR = 0.47; 95% CI = 0.29&#8211;0.77). In subgroup analyses, beneficial effects on both cancer development and mortality persisted in patients &#8805;65 years old, patients with normal blood pressure, and patients with high fasting glucose levels. There were no such associations with long-term statin use (&gt;545 days). Thus, the current nationwide cohort study suggests that prior short-term statin use may have anti-gastric cancer benefits in elderly patients with hyperglycemia. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 785, tag: div, level: 13" node_number="785"> (This article belongs to the Special Issue Statins Use and Cancer) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 786, tag: div, level: 13" node_number="786"><div class="valid" valid="valid" title="valid: True, node: 787, tag: div, level: 14" node_number="787"><div title="valid: False, node: 788, tag: div, level: 15" node_number="788"><p title="valid: False, node: 789, tag: p, level: 16" node_number="789">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 790, tag: div, level: 10" node_number="790"> <div class="valid" valid="valid" title="valid: True, node: 791, tag: div, level: 11" node_number="791"> <div class="valid" valid="valid" title="valid: True, node: 792, tag: div, level: 12" node_number="792"> <div class="valid" valid="valid" title="valid: True, node: 793, tag: div, level: 13" node_number="793"> <a class="valid" valid="valid" title="valid: True, node: 794, tag: a, level: 14" node_number="794"> <i title="valid: False, node: 795, tag: i, level: 15" node_number="795">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 796, tag: div, level: 14" node_number="796"> Supplementary material: Supplementary File 1 (ZIP, 970 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 797, tag: div, level: 13" node_number="797"> <a class="valid" valid="valid" title="valid: True, node: 798, tag: a, level: 14" node_number="798"> <i title="valid: False, node: 799, tag: i, level: 15" node_number="799">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 800, tag: div, level: 13" node_number="800"> <a class="valid" valid="valid" title="valid: True, node: 801, tag: a, level: 14" node_number="801"> <i title="valid: False, node: 802, tag: i, level: 15" node_number="802">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 803, tag: div, level: 14" node_number="803"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 804, tag: div, level: 13" node_number="804">Open AccessArticle</div> Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study <div class="valid" valid="valid" title="valid: True, node: 805, tag: div, level: 13" node_number="805"> by Romain Galy, <span class="valid" valid="valid" title="valid: True, node: 806, tag: span, level: 14" node_number="806"><div title="valid: False, node: 807, tag: div, level: 15" node_number="807">St&#233;phanie Ballereau</div>, </span><span class="valid" valid="valid" title="valid: True, node: 808, tag: span, level: 14" node_number="808"><div title="valid: False, node: 809, tag: div, level: 15" node_number="809">Yves G&#233;nisson</div>, </span><span class="valid" valid="valid" title="valid: True, node: 810, tag: span, level: 14" node_number="810"><div title="valid: False, node: 811, tag: div, level: 15" node_number="811">Lionel Mourey</div>, </span>Jean-Christophe Plaquevent and <span class="valid" valid="valid" title="valid: True, node: 812, tag: span, level: 14" node_number="812"><div title="valid: False, node: 813, tag: div, level: 15" node_number="813">Laurent Maveyraud</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 814, tag: div, level: 13" node_number="814"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 815, tag: b, level: 14" node_number="815">2021</b>, 14(12), 1282; https://doi.org/10.3390/ph14121282 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 816, tag: div, level: 13" node_number="816"> Abstract <div class="valid" valid="valid" title="valid: True, node: 817, tag: div, level: 14" node_number="817"> The mycolic acid biosynthetic pathway represents a promising source of pharmacological targets in the fight against tuberculosis. In <i title="valid: False, node: 818, tag: i, level: 15" node_number="818">Mycobacterium tuberculosis</i>, mycolic acids are subject to specific chemical modifications introduced by a set of eight S-adenosylmethionine dependent methyltransferases. Among these, Hma (MmaA4) is [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 819, tag: div, level: 14" node_number="819"> The mycolic acid biosynthetic pathway represents a promising source of pharmacological targets in the fight against tuberculosis. In <i title="valid: False, node: 820, tag: i, level: 15" node_number="820">Mycobacterium tuberculosis</i>, mycolic acids are subject to specific chemical modifications introduced by a set of eight S-adenosylmethionine dependent methyltransferases. Among these, Hma (MmaA4) is responsible for the introduction of oxygenated modifications. Crystallographic screening of a library of fragments allowed the identification of seven ligands of Hma. Two mutually exclusive binding modes were identified, depending on the conformation of residues 147&#8211;154. These residues are disordered in <i title="valid: False, node: 821, tag: i, level: 15" node_number="821">apo</i>-Hma but fold upon binding of the S-adenosylmethionine (SAM) cofactor as well as of analogues, resulting in the formation of the short &#951;1-helix. One of the observed conformations would be incompatible with the presence of the cofactor, suggesting that allosteric inhibitors could be designed against Hma. Chimeric compounds were designed by fusing some of the bound fragments, and the relative binding affinities of initial fragments and evolved compounds were investigated using molecular dynamics simulation and generalised Born and Poisson&#8211;Boltzmann calculations coupled to the surface area continuum solvation method. Molecular dynamics simulations were also performed on <i title="valid: False, node: 822, tag: i, level: 15" node_number="822">apo</i>-Hma to assess the structural plasticity of the unliganded protein. Our results indicate a significant improvement in the binding properties of the designed compounds, suggesting that they could be further optimised to inhibit Hma activity. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 823, tag: div, level: 13" node_number="823"> (This article belongs to the Special Issue In Silico Approaches in Drug Design) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 824, tag: div, level: 13" node_number="824"><div class="valid" valid="valid" title="valid: True, node: 825, tag: div, level: 14" node_number="825"><div title="valid: False, node: 826, tag: div, level: 15" node_number="826"><p title="valid: False, node: 827, tag: p, level: 16" node_number="827">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 10" node_number="828"> <div class="valid" valid="valid" title="valid: True, node: 829, tag: div, level: 11" node_number="829"> <div class="valid" valid="valid" title="valid: True, node: 830, tag: div, level: 12" node_number="830"> <div class="valid" valid="valid" title="valid: True, node: 831, tag: div, level: 13" node_number="831"> <a class="valid" valid="valid" title="valid: True, node: 832, tag: a, level: 14" node_number="832"> <i title="valid: False, node: 833, tag: i, level: 15" node_number="833">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 834, tag: div, level: 13" node_number="834"> <a class="valid" valid="valid" title="valid: True, node: 835, tag: a, level: 14" node_number="835"> <i title="valid: False, node: 836, tag: i, level: 15" node_number="836">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 837, tag: div, level: 14" node_number="837"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 838, tag: div, level: 13" node_number="838">Open AccessArticle</div> Green-Synthesized Magnesium Hydroxide Nanoparticles Induced Osteoblastic Differentiation in Bone Co-Cultured Cells <div class="valid" valid="valid" title="valid: True, node: 839, tag: div, level: 13" node_number="839"> by <span class="valid" valid="valid" title="valid: True, node: 840, tag: span, level: 14" node_number="840"><div title="valid: False, node: 841, tag: div, level: 15" node_number="841">Laura Costa Pinho</div>, </span><span class="valid" valid="valid" title="valid: True, node: 842, tag: span, level: 14" node_number="842"><div title="valid: False, node: 843, tag: div, level: 15" node_number="843">Marta M. Alves</div>, </span><span class="valid" valid="valid" title="valid: True, node: 844, tag: span, level: 14" node_number="844"><div title="valid: False, node: 845, tag: div, level: 15" node_number="845">Bruno Cola&#231;o</div>, </span><span class="valid" valid="valid" title="valid: True, node: 846, tag: span, level: 14" node_number="846"><div title="valid: False, node: 847, tag: div, level: 15" node_number="847">Maria Helena Fernandes</div> and </span><span class="valid" valid="valid" title="valid: True, node: 848, tag: span, level: 14" node_number="848"><div title="valid: False, node: 849, tag: div, level: 15" node_number="849">Catarina Santos</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 850, tag: div, level: 13" node_number="850"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 851, tag: b, level: 14" node_number="851">2021</b>, 14(12), 1281; https://doi.org/10.3390/ph14121281 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 852, tag: div, level: 13" node_number="852"> Abstract <div class="valid" valid="valid" title="valid: True, node: 853, tag: div, level: 14" node_number="853"> In this work, magnesium hydroxide NPs were synthesized using water (Mg(OH)<sub title="valid: False, node: 854, tag: sub, level: 15" node_number="854">2</sub> NPs) or a rose hip (RH) extract (Mg(OH)<sub title="valid: False, node: 855, tag: sub, level: 15" node_number="855">2</sub>RH NPs) and tested for the bone cells&#8217; effects in co-cultured osteoblastic and osteoclastic cells, using a Transwell<sup title="valid: False, node: 856, tag: sup, level: 15" node_number="856">&#174;</sup> insert system, allowing [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 857, tag: div, level: 14" node_number="857"> In this work, magnesium hydroxide NPs were synthesized using water (Mg(OH)<sub title="valid: False, node: 858, tag: sub, level: 15" node_number="858">2</sub> NPs) or a rose hip (RH) extract (Mg(OH)<sub title="valid: False, node: 859, tag: sub, level: 15" node_number="859">2</sub>RH NPs) and tested for the bone cells&#8217; effects in co-cultured osteoblastic and osteoclastic cells, using a Transwell<sup title="valid: False, node: 860, tag: sup, level: 15" node_number="860">&#174;</sup> insert system, allowing reciprocal cell paracrine interactions. Behavior of each cell population was characterized for typical phenotype markers, at days 1 and 6. Cell cultures treated with osteogenic/osteoclastogenic inducers were used as positive control of cell differentiation. The NPs presented a round shape morphology with an average diameter ~90 nm (Mg(OH)<sub title="valid: False, node: 861, tag: sub, level: 15" node_number="861">2</sub> NPs) and below 10 nm (Mg(OH)<sub title="valid: False, node: 862, tag: sub, level: 15" node_number="862">2</sub>RH NPs. Both NPs induced osteoblastic and osteoclastic behavior similarly to that observed in induced osteoblastic and osteoclastic cultures (positive controls). Differences between the two types of particles were evident at the gene expression level. Compared to Mg(OH)<sub title="valid: False, node: 863, tag: sub, level: 15" node_number="863">2</sub> NPs, the green-synthesized NPs greatly increased the expression of osteoblastic genes coding for the early markers ALP and collagen type 1 and the later transcription factor osterix, while decreasing the expression of osteoclastogenic genes, namely the essential transcription factor NFATC1, TRAP and the genes coding for the functional markers CA2 and CTSK. Overall, a positive added effect could be hypothesized for Mg(OH)<sub title="valid: False, node: 864, tag: sub, level: 15" node_number="864">2</sub>RH NPs with potential usefulness to promote bone formation in regenerative applications. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 865, tag: div, level: 13" node_number="865"> (This article belongs to the Special Issue Synthesis of Metal Nanoparticles and Their Pharmaceutical Applications) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 866, tag: div, level: 13" node_number="866"><div class="valid" valid="valid" title="valid: True, node: 867, tag: div, level: 14" node_number="867"><div title="valid: False, node: 868, tag: div, level: 15" node_number="868"><p title="valid: False, node: 869, tag: p, level: 16" node_number="869">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 870, tag: div, level: 10" node_number="870"> <div class="valid" valid="valid" title="valid: True, node: 871, tag: div, level: 11" node_number="871"> <div class="valid" valid="valid" title="valid: True, node: 872, tag: div, level: 12" node_number="872"> <div class="valid" valid="valid" title="valid: True, node: 873, tag: div, level: 13" node_number="873"> <a class="valid" valid="valid" title="valid: True, node: 874, tag: a, level: 14" node_number="874"> <i title="valid: False, node: 875, tag: i, level: 15" node_number="875">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 876, tag: div, level: 14" node_number="876"> Supplementary material: Supplementary File 1 (ZIP, 160 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 877, tag: div, level: 13" node_number="877"> <a class="valid" valid="valid" title="valid: True, node: 878, tag: a, level: 14" node_number="878"> <i title="valid: False, node: 879, tag: i, level: 15" node_number="879">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 880, tag: div, level: 13" node_number="880"> <a class="valid" valid="valid" title="valid: True, node: 881, tag: a, level: 14" node_number="881"> <i title="valid: False, node: 882, tag: i, level: 15" node_number="882">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 883, tag: div, level: 14" node_number="883"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 884, tag: div, level: 13" node_number="884">Open AccessSystematic Review</div> Adipose Tissue-Derived Mesenchymal Stem Cells as a Potential Restorative Treatment for Cartilage Defects: A PRISMA Review and Meta-Analysis <div class="valid" valid="valid" title="valid: True, node: 885, tag: div, level: 13" node_number="885"> by <span class="valid" valid="valid" title="valid: True, node: 886, tag: span, level: 14" node_number="886"><div title="valid: False, node: 887, tag: div, level: 15" node_number="887">Henry Yue-Hong Meng</div>, </span><span class="valid" valid="valid" title="valid: True, node: 888, tag: span, level: 14" node_number="888"><div title="valid: False, node: 889, tag: div, level: 15" node_number="889">Victor Lu</div> and </span><span class="valid" valid="valid" title="valid: True, node: 890, tag: span, level: 14" node_number="890"><div title="valid: False, node: 891, tag: div, level: 15" node_number="891">Wasim Khan</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 892, tag: div, level: 13" node_number="892"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 893, tag: b, level: 14" node_number="893">2021</b>, 14(12), 1280; https://doi.org/10.3390/ph14121280 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 894, tag: div, level: 13" node_number="894"> Abstract <div class="valid" valid="valid" title="valid: True, node: 895, tag: div, level: 14" node_number="895"> Cartilage defects are a predisposing factor for osteoarthritis. Conventional therapies are mostly palliative and there is an interest in developing newer therapies that target the disease&#8217;s progression. Mesenchymal stem cells (MSCs) have been suggested as a promising therapy to restore hyaline cartilage to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 896, tag: div, level: 14" node_number="896"> Cartilage defects are a predisposing factor for osteoarthritis. Conventional therapies are mostly palliative and there is an interest in developing newer therapies that target the disease&#8217;s progression. Mesenchymal stem cells (MSCs) have been suggested as a promising therapy to restore hyaline cartilage to cartilage defects, though the optimal cell source has remained under investigation. A PRISMA systematic review was conducted utilising five databases (MEDLINE, EMBASE, Cochrane Library, Scopus, Web of Science) which identified nineteen human studies that used adipose tissue-derived MSC (AMSC)-based therapies, including culture-expanded AMSCs and stromal vascular fraction, to treat cartilage defects. Clinical, imaging and histological outcomes, as well as other relevant details pertaining to cartilage regeneration, were extracted from each study. Pooled analysis revealed a significant improvement in WOMAC scores (mean difference: &#8722;25.52; 95%CI (&#8722;30.93, &#8722;20.10); <i title="valid: False, node: 897, tag: i, level: 15" node_number="897">p</i> &lt; 0.001), VAS scores (mean difference: &#8722;3.30; 95%CI (&#8722;3.72, &#8722;2.89); <i title="valid: False, node: 898, tag: i, level: 15" node_number="898">p</i> &lt; 0.001), KOOS scores and end point MOCART score (mean: 68.12; 95%CI (62.18, 74.05)), thus showing improvement. The studies in this review demonstrate the safety and efficacy of AMSC-based therapies for cartilage defects. Establishing standardised methods for MSC extraction and delivery, and performing studies with long follow-up should enable future high-quality research to provide the evidence needed to bring AMSC-based therapies into the market. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 899, tag: div, level: 13" node_number="899"> (This article belongs to the Special Issue Cell-Based Therapies for Bone and Cartilage Regeneration) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 900, tag: div, level: 13" node_number="900"><div class="valid" valid="valid" title="valid: True, node: 901, tag: div, level: 14" node_number="901"><div title="valid: False, node: 902, tag: div, level: 15" node_number="902"><p title="valid: False, node: 903, tag: p, level: 16" node_number="903">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 904, tag: div, level: 10" node_number="904"> <div class="valid" valid="valid" title="valid: True, node: 905, tag: div, level: 11" node_number="905"> <div class="valid" valid="valid" title="valid: True, node: 906, tag: div, level: 12" node_number="906"> <div class="valid" valid="valid" title="valid: True, node: 907, tag: div, level: 13" node_number="907"> <a class="valid" valid="valid" title="valid: True, node: 908, tag: a, level: 14" node_number="908"> <i title="valid: False, node: 909, tag: i, level: 15" node_number="909">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 910, tag: div, level: 13" node_number="910"> <a class="valid" valid="valid" title="valid: True, node: 911, tag: a, level: 14" node_number="911"> <i title="valid: False, node: 912, tag: i, level: 15" node_number="912">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 913, tag: div, level: 14" node_number="913"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 914, tag: div, level: 13" node_number="914">Open AccessArticle</div> Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose <div class="valid" valid="valid" title="valid: True, node: 915, tag: div, level: 13" node_number="915"> by <span class="valid" valid="valid" title="valid: True, node: 916, tag: span, level: 14" node_number="916"><div title="valid: False, node: 917, tag: div, level: 15" node_number="917">Matthew S. Ellis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 918, tag: span, level: 14" node_number="918"><div title="valid: False, node: 919, tag: div, level: 15" node_number="919">Zachary A. Kasper</div>, </span><span class="valid" valid="valid" title="valid: True, node: 920, tag: span, level: 14" node_number="920"><div title="valid: False, node: 921, tag: div, level: 15" node_number="921">Mark Gold</div> and </span><span class="valid" valid="valid" title="valid: True, node: 922, tag: span, level: 14" node_number="922"><div title="valid: False, node: 923, tag: div, level: 15" node_number="923">Theodore J. Cicero</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 924, tag: div, level: 13" node_number="924"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 925, tag: b, level: 14" node_number="925">2021</b>, 14(12), 1279; https://doi.org/10.3390/ph14121279 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 926, tag: div, level: 13" node_number="926"> Abstract <div class="valid" valid="valid" title="valid: True, node: 927, tag: div, level: 14" node_number="927"> While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified. However, there is little data in assessing the relationship between risk factor prevalence, associated provider communication, and subsequent perceptions of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 928, tag: div, level: 14" node_number="928"> While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified. However, there is little data in assessing the relationship between risk factor prevalence, associated provider communication, and subsequent perceptions of overdose risk among chronic pain, opioid-managed (CPOM) patients. An online questionnaire was distributed in June 2020 to a sample of CPOM individuals (n = 190) treated with an opioid prescription at or above 50 daily MME, or any dosage alongside benzodiazepines. CPOM individuals reported a mean daily MME of 470, with half (52.6%) receiving a concurrent benzodiazepine prescription. All patients reported past month alcohol use, and 67.4% indicated a risk-elevating diagnosed medical condition. In assessing provider communication, 41.6% reported no discussion focusing on the risks of one&#8217;s opioid therapy. Subsequently, 62.1% perceived themselves as having &#8220;no risk&#8221;, and 60.0% were &#8220;not at all concerned&#8221; (60.0%) about experiencing an opioid overdose. Organizational policies should focus on implementing consistent methods of patient education regarding overdose risk, as well as assessments of behaviors or characteristics that my increase an individual&#8217;s risk of opioid overdose. These policies should also include other forms of evidence-based overdose risk prevention such as co-prescriptions of naloxone. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 929, tag: div, level: 13" node_number="929"> (This article belongs to the Special Issue Medicinal Chemistry and Pharmacological Activities of Opioid Drugs) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 930, tag: div, level: 13" node_number="930"><div class="valid" valid="valid" title="valid: True, node: 931, tag: div, level: 14" node_number="931"><div title="valid: False, node: 932, tag: div, level: 15" node_number="932"><p title="valid: False, node: 933, tag: p, level: 16" node_number="933">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 934, tag: div, level: 10" node_number="934"> <div class="valid" valid="valid" title="valid: True, node: 935, tag: div, level: 11" node_number="935"> <div class="valid" valid="valid" title="valid: True, node: 936, tag: div, level: 12" node_number="936"> <div class="valid" valid="valid" title="valid: True, node: 937, tag: div, level: 13" node_number="937"> <a class="valid" valid="valid" title="valid: True, node: 938, tag: a, level: 14" node_number="938"> <i title="valid: False, node: 939, tag: i, level: 15" node_number="939">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 940, tag: div, level: 13" node_number="940"> <a class="valid" valid="valid" title="valid: True, node: 941, tag: a, level: 14" node_number="941"> <i title="valid: False, node: 942, tag: i, level: 15" node_number="942">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 943, tag: div, level: 14" node_number="943"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 944, tag: div, level: 13" node_number="944">Open AccessConference Report</div> 29th Annual GP2A Medicinal Chemistry Conference <div class="valid" valid="valid" title="valid: True, node: 945, tag: div, level: 13" node_number="945"> by <span class="valid" valid="valid" title="valid: True, node: 946, tag: span, level: 14" node_number="946"><div title="valid: False, node: 947, tag: div, level: 15" node_number="947">Jean-Jacques Helesbeux</div>, </span><span class="valid" valid="valid" title="valid: True, node: 948, tag: span, level: 14" node_number="948"><div title="valid: False, node: 949, tag: div, level: 15" node_number="949">Laura Carro</div>, </span><span class="valid" valid="valid" title="valid: True, node: 950, tag: span, level: 14" node_number="950"><div title="valid: False, node: 951, tag: div, level: 15" node_number="951">Florence O. McCarthy</div>, </span><span class="valid" valid="valid" title="valid: True, node: 952, tag: span, level: 14" node_number="952"><div title="valid: False, node: 953, tag: div, level: 15" node_number="953">V&#226;nia M. Moreira</div>, </span><span class="valid" valid="valid" title="valid: True, node: 954, tag: span, level: 14" node_number="954"><div title="valid: False, node: 955, tag: div, level: 15" node_number="955">Francesca Giuntini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 956, tag: span, level: 14" node_number="956"><div title="valid: False, node: 957, tag: div, level: 15" node_number="957">Niamh O&#8217;Boyle</div>, </span><span class="valid" valid="valid" title="valid: True, node: 958, tag: span, level: 14" node_number="958"><div title="valid: False, node: 959, tag: div, level: 15" node_number="959">Susan E. Matthews</div>, </span><span class="valid" valid="valid" title="valid: True, node: 960, tag: span, level: 14" node_number="960"><div title="valid: False, node: 961, tag: div, level: 15" node_number="961">G&#252;l&#351;ah Bayraktar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 962, tag: span, level: 14" node_number="962"><div title="valid: False, node: 963, tag: div, level: 15" node_number="963">Samuel Bertrand</div>, </span><span class="valid" valid="valid" title="valid: True, node: 964, tag: span, level: 14" node_number="964"><div title="valid: False, node: 965, tag: div, level: 15" node_number="965">Christophe Rochais</div> and </span><span class="valid" valid="valid" title="valid: True, node: 966, tag: span, level: 14" node_number="966"><div title="valid: False, node: 967, tag: div, level: 15" node_number="967">Pascal Marchand</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 968, tag: div, level: 13" node_number="968"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 969, tag: b, level: 14" node_number="969">2021</b>, 14(12), 1278; https://doi.org/10.3390/ph14121278 - 07 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 970, tag: div, level: 13" node_number="970"> Abstract <div class="valid" valid="valid" title="valid: True, node: 971, tag: div, level: 14" node_number="971"> The 29th Annual GP<sub title="valid: False, node: 972, tag: sub, level: 15" node_number="972">2</sub>A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021. The meeting brought together [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 973, tag: div, level: 14" node_number="973"> The 29th Annual GP<sub title="valid: False, node: 974, tag: sub, level: 15" node_number="974">2</sub>A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021. The meeting brought together an international delegation of researchers with interests in medicinal chemistry and interfacing disciplines. Abstracts of keynote lectures given by the 10 invited speakers, along with those of the 8 young researcher talks and the 50 flash presentation posters, are included in this report. Like previous editions, the conference was a real success, with high-level scientific discussions on cutting-edge advances in the fields of pharmaceutical chemistry. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 13" node_number="975"> (This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 976, tag: div, level: 13" node_number="976"><div class="valid" valid="valid" title="valid: True, node: 977, tag: div, level: 14" node_number="977"><div title="valid: False, node: 978, tag: div, level: 15" node_number="978"><p title="valid: False, node: 979, tag: p, level: 16" node_number="979">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 980, tag: div, level: 10" node_number="980"> <div class="valid" valid="valid" title="valid: True, node: 981, tag: div, level: 11" node_number="981"> <div class="valid" valid="valid" title="valid: True, node: 982, tag: div, level: 12" node_number="982"> <div class="valid" valid="valid" title="valid: True, node: 983, tag: div, level: 13" node_number="983"> <a class="valid" valid="valid" title="valid: True, node: 984, tag: a, level: 14" node_number="984"> <i title="valid: False, node: 985, tag: i, level: 15" node_number="985">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 986, tag: div, level: 13" node_number="986"> <a class="valid" valid="valid" title="valid: True, node: 987, tag: a, level: 14" node_number="987"> <i title="valid: False, node: 988, tag: i, level: 15" node_number="988">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 14" node_number="989"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 990, tag: div, level: 13" node_number="990">Open AccessArticle</div> A Deep-Learning Proteomic-Scale Approach for Drug Design <div class="valid" valid="valid" title="valid: True, node: 991, tag: div, level: 13" node_number="991"> by <span class="valid" valid="valid" title="valid: True, node: 992, tag: span, level: 14" node_number="992"><div title="valid: False, node: 993, tag: div, level: 15" node_number="993">Brennan Overhoff</div>, </span><span class="valid" valid="valid" title="valid: True, node: 994, tag: span, level: 14" node_number="994"><div title="valid: False, node: 995, tag: div, level: 15" node_number="995">Zackary Falls</div>, </span><span class="valid" valid="valid" title="valid: True, node: 996, tag: span, level: 14" node_number="996"><div title="valid: False, node: 997, tag: div, level: 15" node_number="997">William Mangione</div> and </span><span class="valid" valid="valid" title="valid: True, node: 998, tag: span, level: 14" node_number="998"><div title="valid: False, node: 999, tag: div, level: 15" node_number="999">Ram Samudrala</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 1000, tag: div, level: 13" node_number="1000"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 1001, tag: b, level: 14" node_number="1001">2021</b>, 14(12), 1277; https://doi.org/10.3390/ph14121277 - 07 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 1002, tag: div, level: 13" node_number="1002"> Abstract <div class="valid" valid="valid" title="valid: True, node: 1003, tag: div, level: 14" node_number="1003"> Computational approaches have accelerated novel therapeutic discovery in recent decades. The Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun multitarget therapeutic discovery, repurposing, and design aims to improve their efficacy and safety by employing a holistic approach that computes interaction signatures [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 1004, tag: div, level: 14" node_number="1004"> Computational approaches have accelerated novel therapeutic discovery in recent decades. The Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun multitarget therapeutic discovery, repurposing, and design aims to improve their efficacy and safety by employing a holistic approach that computes interaction signatures between every drug/compound and a large library of non-redundant protein structures corresponding to the human proteome fold space. These signatures are compared and analyzed to determine if a given drug/compound is efficacious and safe for a given indication/disease. In this study, we used a deep learning-based autoencoder to first reduce the dimensionality of CANDO-computed drug&#8211;proteome interaction signatures. We then employed a reduced conditional variational autoencoder to generate novel drug-like compounds when given a target encoded &#8220;objective&#8221; signature. Using this approach, we designed compounds to recreate the interaction signatures for twenty approved and experimental drugs and showed that 16/20 designed compounds were predicted to be significantly (<i title="valid: False, node: 1005, tag: i, level: 15" node_number="1005">p</i>-value &#8804; 0.05) more behaviorally similar relative to all corresponding controls, and 20/20 were predicted to be more behaviorally similar relative to a random control. We further observed that redesigns of objectives developed via rational drug design performed significantly better than those derived from natural sources (<i title="valid: False, node: 1006, tag: i, level: 15" node_number="1006">p</i>-value &#8804; 0.05), suggesting that the model learned an abstraction of rational drug design. We also show that the designed compounds are structurally diverse and synthetically feasible when compared to their respective objective drugs despite consistently high predicted behavioral similarity. Finally, we generated new designs that enhanced thirteen drugs/compounds associated with non-small cell lung cancer and anti-aging properties using their predicted proteomic interaction signatures. his study represents a significant step forward in automating holistic therapeutic design with machine learning, enabling the rapid generation of novel, effective, and safe drug leads for any indication. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1007, tag: div, level: 13" node_number="1007"> (This article belongs to the Special Issue In Silico Approaches in Drug Design) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 1008, tag: div, level: 13" node_number="1008"><div class="valid" valid="valid" title="valid: True, node: 1009, tag: div, level: 14" node_number="1009"><div title="valid: False, node: 1010, tag: div, level: 15" node_number="1010"><p title="valid: False, node: 1011, tag: p, level: 16" node_number="1011">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1012, tag: div, level: 10" node_number="1012"> <div class="valid" valid="valid" title="valid: True, node: 1013, tag: div, level: 11" node_number="1013"> <div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 12" node_number="1014"> <div class="valid" valid="valid" title="valid: True, node: 1015, tag: div, level: 13" node_number="1015"> <a class="valid" valid="valid" title="valid: True, node: 1016, tag: a, level: 14" node_number="1016"> <i title="valid: False, node: 1017, tag: i, level: 15" node_number="1017">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1018, tag: div, level: 13" node_number="1018"> <a class="valid" valid="valid" title="valid: True, node: 1019, tag: a, level: 14" node_number="1019"> <i title="valid: False, node: 1020, tag: i, level: 15" node_number="1020">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 1021, tag: div, level: 14" node_number="1021"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1022, tag: div, level: 13" node_number="1022">Open AccessArticle</div> Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury&#8212;Cardioprotective Properties of Carvedilol <div class="valid" valid="valid" title="valid: True, node: 1023, tag: div, level: 13" node_number="1023"> by <span class="valid" valid="valid" title="valid: True, node: 1024, tag: span, level: 14" node_number="1024"><div title="valid: False, node: 1025, tag: div, level: 15" node_number="1025">Monika Skrzypiec-Spring</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1026, tag: span, level: 14" node_number="1026"><div title="valid: False, node: 1027, tag: div, level: 15" node_number="1027">Joanna Urbaniak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1028, tag: span, level: 14" node_number="1028"><div title="valid: False, node: 1029, tag: div, level: 15" node_number="1029">Agnieszka Sapa-Wojciechowska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1030, tag: span, level: 14" node_number="1030"><div title="valid: False, node: 1031, tag: div, level: 15" node_number="1031">Jadwiga Pietkiewicz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1032, tag: span, level: 14" node_number="1032"><div title="valid: False, node: 1033, tag: div, level: 15" node_number="1033">Alina Orda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1034, tag: span, level: 14" node_number="1034"><div title="valid: False, node: 1035, tag: div, level: 15" node_number="1035">Bo&#380;ena Karolko</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1036, tag: span, level: 14" node_number="1036"><div title="valid: False, node: 1037, tag: div, level: 15" node_number="1037">Regina Danielewicz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1038, tag: span, level: 14" node_number="1038"><div title="valid: False, node: 1039, tag: div, level: 15" node_number="1039">Iwona Bil-Lula</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1040, tag: span, level: 14" node_number="1040"><div title="valid: False, node: 1041, tag: div, level: 15" node_number="1041">Mieczys&#322;aw Wo&#378;niak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 1042, tag: span, level: 14" node_number="1042"><div title="valid: False, node: 1043, tag: div, level: 15" node_number="1043">Richard Schulz</div> and </span><span class="valid" valid="valid" title="valid: True, node: 1044, tag: span, level: 14" node_number="1044"><div title="valid: False, node: 1045, tag: div, level: 15" node_number="1045">Adam Szel&#261;g</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 1046, tag: div, level: 13" node_number="1046"> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 1047, tag: b, level: 14" node_number="1047">2021</b>, 14(12), 1276; https://doi.org/10.3390/ph14121276 - 07 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 1048, tag: div, level: 13" node_number="1048"> Abstract <div class="valid" valid="valid" title="valid: True, node: 1049, tag: div, level: 14" node_number="1049"> Matrix metalloproteinase 2 (MMP-2) is activated in hearts upon ischemia-reperfusion (IR) injury and cleaves sarcomeric proteins. It was shown that carvedilol and nebivolol reduced the activity of different MMPs. Hence, we hypothesized that they could reduce MMPs activation in myocytes, and therefore, protect [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 1050, tag: div, level: 14" node_number="1050"> Matrix metalloproteinase 2 (MMP-2) is activated in hearts upon ischemia-reperfusion (IR) injury and cleaves sarcomeric proteins. It was shown that carvedilol and nebivolol reduced the activity of different MMPs. Hence, we hypothesized that they could reduce MMPs activation in myocytes, and therefore, protect against cardiac contractile dysfunction related with IR injury. Isolated rat hearts were subjected to either control aerobic perfusion or IR injury: 25 min of aerobic perfusion, followed by 20 min global, no-flow ischemia, and reperfusion for 30 min. The effects of carvedilol, nebivolol, or metoprolol were evaluated in hearts subjected to IR injury. Cardiac mechanical function and MMP-2 activity in the heart homogenates and coronary effluent were assessed along with troponin I content in the former. Only carvedilol improved the recovery of mechanical function at the end of reperfusion compared to IR injury hearts. IR injury induced the activation and release of MMP-2 into the coronary effluent during reperfusion. MMP-2 activity in the coronary effluent increased in the IR injury group and this was prevented by carvedilol. Troponin I levels decreased by 73% in IR hearts and this was abolished by carvedilol. Conclusions: These data suggest that the cardioprotective effect of carvedilol in myocardial IR injury may be mediated by inhibiting MMP-2 activation. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1051, tag: div, level: 13" node_number="1051"> (This article belongs to the Special Issue Novel Approaches for Targeting Metalloproteinases) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 1052, tag: div, level: 13" node_number="1052"><div class="valid" valid="valid" title="valid: True, node: 1053, tag: div, level: 14" node_number="1053"><div title="valid: False, node: 1054, tag: div, level: 15" node_number="1054"><p title="valid: False, node: 1055, tag: p, level: 16" node_number="1055">Figure 1</p></div></div></div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1056, tag: div, level: 9" node_number="1056"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1057, tag: div, level: 6" node_number="1057"> <div class="valid" valid="valid" title="valid: True, node: 1058, tag: div, level: 7" node_number="1058"> <div class="valid" valid="valid" title="valid: True, node: 1059, tag: div, level: 8" node_number="1059"> <div class="valid" valid="valid" title="valid: True, node: 1060, tag: div, level: 9" node_number="1060"> <a class="valid" valid="valid" title="valid: True, node: 1061, tag: a, level: 10" node_number="1061"> Submit to <i class="valid" valid="valid" title="valid: True, node: 1062, tag: i, level: 11" node_number="1062">Pharmaceuticals</i> </a> Review for Pharmaceuticals <div class="valid" valid="valid" title="valid: True, node: 1063, tag: div, level: 10" node_number="1063"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1064, tag: div, level: 9" node_number="1064"> <h2 class="valid" valid="valid" title="valid: True, node: 1065, tag: h2, level: 10" node_number="1065">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 1066, tag: ul, level: 10" node_number="1066"> <li class="valid" valid="valid" title="valid: True, node: 1067, tag: li, level: 11" node_number="1067"> <ul class="valid" valid="valid" title="valid: True, node: 1068, tag: ul, level: 12" node_number="1068"> <li class="valid" valid="valid" title="valid: True, node: 1069, tag: li, level: 13" node_number="1069"> Pharmaceuticals Home </li> <li class="valid" valid="valid" title="valid: True, node: 1070, tag: li, level: 13" node_number="1070"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 1071, tag: li, level: 13" node_number="1071"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 1072, tag: li, level: 13" node_number="1072"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 1073, tag: li, level: 13" node_number="1073"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 1074, tag: li, level: 13" node_number="1074"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 1075, tag: li, level: 13" node_number="1075"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 1076, tag: li, level: 13" node_number="1076"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 1077, tag: li, level: 13" node_number="1077"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 1078, tag: li, level: 13" node_number="1078"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 1079, tag: li, level: 13" node_number="1079"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 1080, tag: li, level: 13" node_number="1080"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 1081, tag: li, level: 13" node_number="1081"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 1082, tag: li, level: 13" node_number="1082"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 1083, tag: li, level: 13" node_number="1083"> Society Collaborations </li> <li class="valid" valid="valid" title="valid: True, node: 1084, tag: li, level: 13" node_number="1084"> Conferences </li> <li class="valid" valid="valid" title="valid: True, node: 1085, tag: li, level: 13" node_number="1085"> Editorial Office </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 1086, tag: h2, level: 9" node_number="1086">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 1087, tag: div, level: 9" node_number="1087"> <div class="valid" valid="valid" title="valid: True, node: 1088, tag: div, level: 10" node_number="1088"> <ul class="valid" valid="valid" title="valid: True, node: 1089, tag: ul, level: 11" node_number="1089"> <li class="valid" valid="valid" title="valid: True, node: 1090, tag: li, level: 12" node_number="1090"> <a class="valid" valid="valid" title="valid: True, node: 1091, tag: a, level: 13" node_number="1091"> <i class="valid" valid="valid" title="valid: True, node: 1092, tag: i, level: 14" node_number="1092"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 1093, tag: a, level: 13" node_number="1093"> <i class="valid" valid="valid" title="valid: True, node: 1094, tag: i, level: 14" node_number="1094"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 1095, tag: div, level: 12" node_number="1095"> <div class="valid" valid="valid" title="valid: True, node: 1096, tag: div, level: 13" node_number="1096"> <div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 14" node_number="1097"> <li title="valid: False, node: 1098, tag: li, level: 15" node_number="1098"> Vol.&#160;14&#160;(2021) </li> <li title="valid: False, node: 1099, tag: li, level: 15" node_number="1099"> Vol.&#160;13&#160;(2020) </li> <li title="valid: False, node: 1100, tag: li, level: 15" node_number="1100"> Vol.&#160;12&#160;(2019) </li> <li title="valid: False, node: 1101, tag: li, level: 15" node_number="1101"> Vol.&#160;11&#160;(2018) </li> <li title="valid: False, node: 1102, tag: li, level: 15" node_number="1102"> Vol.&#160;10&#160;(2017) </li> <li title="valid: False, node: 1103, tag: li, level: 15" node_number="1103"> Vol.&#160;9&#160;(2016) </li> <li title="valid: False, node: 1104, tag: li, level: 15" node_number="1104"> Vol.&#160;8&#160;(2015) </li> <li title="valid: False, node: 1105, tag: li, level: 15" node_number="1105"> Vol.&#160;7&#160;(2014) </li> <li title="valid: False, node: 1106, tag: li, level: 15" node_number="1106"> Vol.&#160;6&#160;(2013) </li> <li title="valid: False, node: 1107, tag: li, level: 15" node_number="1107"> Vol.&#160;5&#160;(2012) </li> <li title="valid: False, node: 1108, tag: li, level: 15" node_number="1108"> Vol.&#160;4&#160;(2011) </li> <li title="valid: False, node: 1109, tag: li, level: 15" node_number="1109"> Vol.&#160;3&#160;(2010) </li> <li title="valid: False, node: 1110, tag: li, level: 15" node_number="1110"> Vol.&#160;2&#160;(2009) </li> <li title="valid: False, node: 1111, tag: li, level: 15" node_number="1111"> Vol.&#160;1&#160;(2004) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1112, tag: div, level: 7" node_number="1112"> <div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 8" node_number="1113"> <h2 class="valid" valid="valid" title="valid: True, node: 1114, tag: h2, level: 9" node_number="1114">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 8" node_number="1115"> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 9" node_number="1116"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1117, tag: div, level: 7" node_number="1117"> <div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 8" node_number="1118"> <h2 class="valid" valid="valid" title="valid: True, node: 1119, tag: h2, level: 9" node_number="1119">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1120, tag: div, level: 8" node_number="1120"> <div class="valid" valid="valid" title="valid: True, node: 1121, tag: div, level: 9" node_number="1121"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1122, tag: div, level: 6" node_number="1122"> <div class="valid" valid="valid" title="valid: True, node: 1123, tag: div, level: 7" node_number="1123"> <div class="valid" valid="valid" title="valid: True, node: 1124, tag: div, level: 8" node_number="1124"> <h2 class="valid" valid="valid" title="valid: True, node: 1125, tag: h2, level: 9" node_number="1125">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1126, tag: div, level: 7" node_number="1126"> <div class="valid" valid="valid" title="valid: True, node: 1127, tag: div, level: 8" node_number="1127"> <h2 class="valid" valid="valid" title="valid: True, node: 1128, tag: h2, level: 9" node_number="1128">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1129, tag: div, level: 8" node_number="1129"> <div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 9" node_number="1130"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 9" node_number="1131"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 9" node_number="1132"> 26 October 2021 Journal of Nanotheranostics | JNT 2022 Travel Awards&#8212;Open for Application </div> <div class="valid" valid="valid" title="valid: True, node: 1133, tag: div, level: 9" node_number="1133"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 7" node_number="1134"> <div class="valid" valid="valid" title="valid: True, node: 1135, tag: div, level: 8" node_number="1135"> <h2 class="valid" valid="valid" title="valid: True, node: 1136, tag: h2, level: 9" node_number="1136">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1137, tag: div, level: 8" node_number="1137"> <div class="valid" valid="valid" title="valid: True, node: 1138, tag: div, level: 9" node_number="1138"><div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 10" node_number="1139"> Topic in Viruses, Biomedicines, Pharmaceuticals, Pharmaceutics, COVID</div> Broad-Spectrum Antiviral Agents Editors-in-Chief: Cheng-Wen Lin, Szu-Hao KungDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 9" node_number="1140"><div class="valid" valid="valid" title="valid: True, node: 1141, tag: div, level: 10" node_number="1141"> Topic in Molecules, Toxics, Pharmaceuticals, BioMed</div> Development of Protective Therapies Facing Toxic Environmental Exposures Editors-in-Chief: Ricardo Lagoa, M&#225;rio DinizDeadline: 31 March 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1142, tag: div, level: 9" node_number="1142"><div class="valid" valid="valid" title="valid: True, node: 1143, tag: div, level: 10" node_number="1143"> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1144, tag: div, level: 9" node_number="1144"><div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 10" node_number="1145"> Topic in Biomedicines, CIMB, IJMS, Neurology International, Pharmaceuticals</div> Neuroprotection by Drugs, Nutraceuticals and Physical Activity Editors-in-Chief: Cristina Angeloni, Andrea TarozziDeadline: 30 September 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1146, tag: div, level: 9" node_number="1146"> More Topics </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1147, tag: div, level: 7" node_number="1147"> <div class="valid" valid="valid" title="valid: True, node: 1148, tag: div, level: 8" node_number="1148"> <h2 class="valid" valid="valid" title="valid: True, node: 1149, tag: h2, level: 9" node_number="1149">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1150, tag: div, level: 8" node_number="1150"> <div class="valid" valid="valid" title="valid: True, node: 1151, tag: div, level: 9" node_number="1151"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1152, tag: div, level: 9" node_number="1152"> 6&#8211;9 September 2022 The 4th ISFMS: Biochemistry, Molecular Biology and Druggability of Proteins</div> <div class="valid" valid="valid" title="valid: True, node: 1153, tag: div, level: 9" node_number="1153"> 13&#8211;17 December 2021 Antibody Engineering Therapeutics 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1154, tag: div, level: 9" node_number="1154"> 19&#8211;22 January 2022 Joint 14th National Organic Chemistry Meeting (14ENQO) and 7th National Medicinal Chemistry Meeting (7ENQT)</div> <div class="valid" valid="valid" title="valid: True, node: 1155, tag: div, level: 9" node_number="1155"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1156, tag: div, level: 7" node_number="1156"> <div class="valid" valid="valid" title="valid: True, node: 1157, tag: div, level: 8" node_number="1157"> <h2 class="valid" valid="valid" title="valid: True, node: 1158, tag: h2, level: 9" node_number="1158">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1159, tag: div, level: 8" node_number="1159"> <div class="valid" valid="valid" title="valid: True, node: 1160, tag: div, level: 9" node_number="1160"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1161, tag: div, level: 9" node_number="1161"><div class="valid" valid="valid" title="valid: True, node: 1162, tag: div, level: 10" node_number="1162"> Special Issue in Pharmaceuticals</div> Epigenetic Drugs Guest Editor: Marcin RatajewskiDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1163, tag: div, level: 9" node_number="1163"><div class="valid" valid="valid" title="valid: True, node: 1164, tag: div, level: 10" node_number="1164"> Special Issue in Pharmaceuticals</div> Selective Chelators for Metals on Cells and Cancer Chemotherapy Guest Editor: Lu&#237;s M. T. FrijaDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1165, tag: div, level: 9" node_number="1165"><div class="valid" valid="valid" title="valid: True, node: 1166, tag: div, level: 10" node_number="1166"> Special Issue in Pharmaceuticals</div> Cancer Translational Biomarkers and Targeted Therapies Guest Editors: Raquel Lima, Marcelo CorreiaDeadline: 15 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1167, tag: div, level: 9" node_number="1167"><div class="valid" valid="valid" title="valid: True, node: 1168, tag: div, level: 10" node_number="1168"> Special Issue in Pharmaceuticals</div> GPCRs: Ligands and beyond 2022 Guest Editors: Erika Cione, Maria Cristina CaroleoDeadline: 20 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1169, tag: div, level: 9" node_number="1169"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1170, tag: div, level: 7" node_number="1170"> <div class="valid" valid="valid" title="valid: True, node: 1171, tag: div, level: 8" node_number="1171"> <h2 class="valid" valid="valid" title="valid: True, node: 1172, tag: h2, level: 9" node_number="1172">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1173, tag: div, level: 8" node_number="1173"> <div class="valid" valid="valid" title="valid: True, node: 1174, tag: div, level: 9" node_number="1174"><div class="valid" valid="valid" title="valid: True, node: 1175, tag: div, level: 10" node_number="1175"> Topical Collection in Pharmaceuticals</div> The Story of Successful Drugs and Recent FDA-Approved Molecules Collection Editors: Jean Jacques Vanden Eynde, Klaus Kopka, Maria Em&#237;lia de Sousa, Annie Mayence, Joachim Jose, Guangshun Wang</div> <div class="valid" valid="valid" title="valid: True, node: 1176, tag: div, level: 9" node_number="1176"><div class="valid" valid="valid" title="valid: True, node: 1177, tag: div, level: 10" node_number="1177"> Topical Collection in Pharmaceuticals</div> Old Pharmaceuticals with New Applications Collection Editor: Maria Em&#237;lia de Sousa</div> <div class="valid" valid="valid" title="valid: True, node: 1178, tag: div, level: 9" node_number="1178"><div class="valid" valid="valid" title="valid: True, node: 1179, tag: div, level: 10" node_number="1179"> Topical Collection in Pharmaceuticals</div> Protein Kinases and Cancer Collection Editors: Khalil Ahmed, Janeen Trembley</div> <div class="valid" valid="valid" title="valid: True, node: 1180, tag: div, level: 9" node_number="1180"><div class="valid" valid="valid" title="valid: True, node: 1181, tag: div, level: 10" node_number="1181"> Topical Collection in Pharmaceuticals</div> New Tools for Medicinal Chemists Collection Editors: Jean Jacques Vanden Eynde, Annie Mayence</div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1182, tag: div, level: 7" node_number="1182"> <div class="valid" valid="valid" title="valid: True, node: 1183, tag: div, level: 8" node_number="1183"> <h2 class="valid" valid="valid" title="valid: True, node: 1184, tag: h2, level: 9" node_number="1184">Conference Reports</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1185, tag: div, level: 8" node_number="1185"> <div class="valid" valid="valid" title="valid: True, node: 1186, tag: div, level: 9" node_number="1186"><div class="valid" valid="valid" title="valid: True, node: 1187, tag: div, level: 10" node_number="1187"> 29th Annual GP2A Medicinal Chemistry Conference </div> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 1188, tag: b, level: 10" node_number="1188">2021</b>, 14(12), 1278; https://doi.org/10.3390/ph14121278 </div> <div class="valid" valid="valid" title="valid: True, node: 1189, tag: div, level: 9" node_number="1189"><div class="valid" valid="valid" title="valid: True, node: 1190, tag: div, level: 10" node_number="1190"> 27th Annual GP2A Medicinal Chemistry Conference </div> Pharmaceuticals <b class="valid" valid="valid" title="valid: True, node: 1191, tag: b, level: 10" node_number="1191">2019</b>, 12(4), 179; https://doi.org/10.3390/ph12040179 </div> <div class="valid" valid="valid" title="valid: True, node: 1192, tag: div, level: 9" node_number="1192"> More Conference Reports... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1193, tag: div, level: 7" node_number="1193"> <div class="valid" valid="valid" title="valid: True, node: 1194, tag: div, level: 8" node_number="1194"> <h2 class="valid" valid="valid" title="valid: True, node: 1195, tag: h2, level: 9" node_number="1195">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1196, tag: div, level: 8" node_number="1196"> <div class="valid" valid="valid" title="valid: True, node: 1197, tag: div, level: 9" node_number="1197"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1198, tag: div, level: 3" node_number="1198"> <div class="valid" valid="valid" title="valid: True, node: 1199, tag: div, level: 4" node_number="1199"> Pharmaceuticals, EISSN 1424-8247, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1200, tag: span, level: 5" node_number="1200"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1201, tag: div, level: 6" node_number="1201"> The statements, opinions and data contained in the journal Pharmaceuticals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1202, tag: div, level: 5" node_number="1202"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1203, tag: div, level: 4" node_number="1203"> <div class="valid" valid="valid" title="valid: True, node: 1204, tag: div, level: 5" node_number="1204"> <h3 class="valid" valid="valid" title="valid: True, node: 1205, tag: h3, level: 6" node_number="1205"> Further Information </h3> <a class="valid" valid="valid" title="valid: True, node: 1206, tag: a, level: 6" node_number="1206"> Article Processing Charges </a> <a class="valid" valid="valid" title="valid: True, node: 1207, tag: a, level: 6" node_number="1207"> Pay an Invoice </a> <a class="valid" valid="valid" title="valid: True, node: 1208, tag: a, level: 6" node_number="1208"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1209, tag: a, level: 6" node_number="1209"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1210, tag: a, level: 6" node_number="1210"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1211, tag: div, level: 5" node_number="1211"> <h3 class="valid" valid="valid" title="valid: True, node: 1212, tag: h3, level: 6" node_number="1212"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1213, tag: a, level: 6" node_number="1213"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1214, tag: a, level: 6" node_number="1214"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1215, tag: a, level: 6" node_number="1215"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1216, tag: a, level: 6" node_number="1216"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1217, tag: a, level: 6" node_number="1217"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1218, tag: a, level: 6" node_number="1218"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1219, tag: div, level: 5" node_number="1219"> <h3 class="valid" valid="valid" title="valid: True, node: 1220, tag: h3, level: 6" node_number="1220"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1221, tag: a, level: 6" node_number="1221"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1222, tag: a, level: 6" node_number="1222"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1223, tag: a, level: 6" node_number="1223"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1224, tag: a, level: 6" node_number="1224"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1225, tag: a, level: 6" node_number="1225"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1226, tag: a, level: 6" node_number="1226"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1227, tag: a, level: 6" node_number="1227"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1228, tag: a, level: 6" node_number="1228"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1229, tag: div, level: 5" node_number="1229"> <h3 class="valid" valid="valid" title="valid: True, node: 1230, tag: h3, level: 6" node_number="1230"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1231, tag: a, level: 6" node_number="1231"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1232, tag: a, level: 6" node_number="1232"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1233, tag: a, level: 6" node_number="1233"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1234, tag: div, level: 4" node_number="1234"> <div class="valid" valid="valid" title="valid: True, node: 1235, tag: div, level: 5" node_number="1235"> <div class="valid" valid="valid" title="valid: True, node: 1236, tag: div, level: 6" node_number="1236"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1237, tag: div, level: 6" node_number="1237"> <a class="valid" valid="valid" title="valid: True, node: 1238, tag: a, level: 7" node_number="1238"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1239, tag: div, level: 7" node_number="1239"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1240, tag: a, level: 7" node_number="1240"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1241, tag: a, level: 7" node_number="1241"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1242, tag: div, level: 3" node_number="1242"> <div class="valid" valid="valid" title="valid: True, node: 1243, tag: div, level: 4" node_number="1243"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1244, tag: a, level: 5" node_number="1244">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1245, tag: div, level: 4" node_number="1245"> <a class="valid" valid="valid" title="valid: True, node: 1246, tag: a, level: 5" node_number="1246">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1247, tag: div, level: 3" node_number="1247"> <div class="valid" valid="valid" title="valid: True, node: 1248, tag: div, level: 4" node_number="1248"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1249, tag: div, level: 4" node_number="1249"> <a class="valid" valid="valid" title="valid: True, node: 1250, tag: a, level: 5" node_number="1250">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1251, tag: div, level: 2" node_number="1251"> <div class="valid" valid="valid" title="valid: True, node: 1252, tag: div, level: 3" node_number="1252"> <div class="valid" valid="valid" title="valid: True, node: 1253, tag: div, level: 4" node_number="1253"> <h2 class="valid" valid="valid" title="valid: True, node: 1254, tag: h2, level: 5" node_number="1254">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1255, tag: div, level: 4" node_number="1255"> <a class="valid" valid="valid" title="valid: True, node: 1256, tag: a, level: 5" node_number="1256">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1257, tag: a, level: 3" node_number="1257"> <i class="valid" valid="valid" title="valid: True, node: 1258, tag: i, level: 4" node_number="1258">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1259, tag: div, level: 2" node_number="1259"> <div class="valid" valid="valid" title="valid: True, node: 1260, tag: div, level: 3" node_number="1260"> <div class="valid" valid="valid" title="valid: True, node: 1261, tag: div, level: 4" node_number="1261"> <h2 class="valid" valid="valid" title="valid: True, node: 1262, tag: h2, level: 5" node_number="1262">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1263, tag: a, level: 3" node_number="1263"> <i class="valid" valid="valid" title="valid: True, node: 1264, tag: i, level: 4" node_number="1264">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1265, tag: a, level: 2" node_number="1265">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>